(260768, 'HP:0012224', 'Circulating immune complexes', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260769, 'HP:0012224', 'Circulating immune complexes', 'MP:0006194', 'keratoconjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260770, 'HP:0012224', 'Circulating immune complexes', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260771, 'HP:0012224', 'Circulating immune complexes', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260772, 'HP:0012224', 'Circulating immune complexes', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260773, 'HP:0012224', 'Circulating immune complexes', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260774, 'HP:0012224', 'Circulating immune complexes', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260775, 'HP:0012224', 'Circulating immune complexes', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260776, 'HP:0012224', 'Circulating immune complexes', 'MP:0005001', 'abnormal clonal deletion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260777, 'HP:0012224', 'Circulating immune complexes', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260778, 'HP:0012224', 'Circulating immune complexes', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260779, 'HP:0012224', 'Circulating immune complexes', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260780, 'HP:0012224', 'Circulating immune complexes', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260781, 'HP:0012224', 'Circulating immune complexes', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260782, 'HP:0012224', 'Circulating immune complexes', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260783, 'HP:0012224', 'Circulating immune complexes', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260784, 'HP:0012224', 'Circulating immune complexes', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260785, 'HP:0012224', 'Circulating immune complexes', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260786, 'HP:0012224', 'Circulating immune complexes', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260787, 'HP:0012224', 'Circulating immune complexes', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260788, 'HP:0012224', 'Circulating immune complexes', 'MP:0001858', 'intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260789, 'HP:0012224', 'Circulating immune complexes', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260790, 'HP:0012224', 'Circulating immune complexes', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260791, 'HP:0012224', 'Circulating immune complexes', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260792, 'HP:0012224', 'Circulating immune complexes', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260793, 'HP:0012224', 'Circulating immune complexes', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260794, 'HP:0012224', 'Circulating immune complexes', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260795, 'HP:0012224', 'Circulating immune complexes', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260796, 'HP:0012224', 'Circulating immune complexes', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260797, 'HP:0012224', 'Circulating immune complexes', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260798, 'HP:0012224', 'Circulating immune complexes', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260799, 'HP:0012224', 'Circulating immune complexes', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260800, 'HP:0012224', 'Circulating immune complexes', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260801, 'HP:0012224', 'Circulating immune complexes', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260802, 'HP:0012224', 'Circulating immune complexes', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260803, 'HP:0012224', 'Circulating immune complexes', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260804, 'HP:0012224', 'Circulating immune complexes', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260805, 'HP:0012224', 'Circulating immune complexes', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260806, 'HP:0012224', 'Circulating immune complexes', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260807, 'HP:0012224', 'Circulating immune complexes', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260808, 'HP:0012224', 'Circulating immune complexes', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260809, 'HP:0012224', 'Circulating immune complexes', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260810, 'HP:0012224', 'Circulating immune complexes', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260811, 'HP:0012224', 'Circulating immune complexes', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260812, 'HP:0012224', 'Circulating immune complexes', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260813, 'HP:0012224', 'Circulating immune complexes', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260814, 'HP:0012224', 'Circulating immune complexes', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260815, 'HP:0012224', 'Circulating immune complexes', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260816, 'HP:0012224', 'Circulating immune complexes', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260817, 'HP:0012224', 'Circulating immune complexes', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260818, 'HP:0012224', 'Circulating immune complexes', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260819, 'HP:0012224', 'Circulating immune complexes', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260820, 'HP:0012224', 'Circulating immune complexes', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260821, 'HP:0012224', 'Circulating immune complexes', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260822, 'HP:0012224', 'Circulating immune complexes', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260823, 'HP:0012224', 'Circulating immune complexes', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260824, 'HP:0012224', 'Circulating immune complexes', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260825, 'HP:0012224', 'Circulating immune complexes', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260826, 'HP:0012224', 'Circulating immune complexes', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260827, 'HP:0012224', 'Circulating immune complexes', 'MP:0020386', 'adipose tissue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260828, 'HP:0012224', 'Circulating immune complexes', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260829, 'HP:0012224', 'Circulating immune complexes', 'MP:0005364', 'increased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260830, 'HP:0012224', 'Circulating immune complexes', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260831, 'HP:0012224', 'Circulating immune complexes', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260832, 'HP:0012224', 'Circulating immune complexes', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260833, 'HP:0012224', 'Circulating immune complexes', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260834, 'HP:0012224', 'Circulating immune complexes', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260835, 'HP:0012224', 'Circulating immune complexes', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260836, 'HP:0012224', 'Circulating immune complexes', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260837, 'HP:0012224', 'Circulating immune complexes', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260838, 'HP:0012224', 'Circulating immune complexes', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260839, 'HP:0012224', 'Circulating immune complexes', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260840, 'HP:0012224', 'Circulating immune complexes', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260841, 'HP:0012224', 'Circulating immune complexes', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260842, 'HP:0012224', 'Circulating immune complexes', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260843, 'HP:0012224', 'Circulating immune complexes', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260844, 'HP:0012224', 'Circulating immune complexes', 'MP:0008747', 'abnormal T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260845, 'HP:0012224', 'Circulating immune complexes', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260846, 'HP:0012224', 'Circulating immune complexes', 'MP:0020142', 'increased anti-sperm antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260847, 'HP:0012224', 'Circulating immune complexes', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260848, 'HP:0012224', 'Circulating immune complexes', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260849, 'HP:0012224', 'Circulating immune complexes', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260850, 'HP:0012224', 'Circulating immune complexes', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260851, 'HP:0012224', 'Circulating immune complexes', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260852, 'HP:0012224', 'Circulating immune complexes', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260853, 'HP:0012224', 'Circulating immune complexes', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260854, 'HP:0012224', 'Circulating immune complexes', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260855, 'HP:0012224', 'Circulating immune complexes', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260856, 'HP:0012224', 'Circulating immune complexes', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260857, 'HP:0012224', 'Circulating immune complexes', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260858, 'HP:0012224', 'Circulating immune complexes', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260859, 'HP:0012224', 'Circulating immune complexes', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260860, 'HP:0012224', 'Circulating immune complexes', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260861, 'HP:0012224', 'Circulating immune complexes', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260862, 'HP:0012224', 'Circulating immune complexes', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260863, 'HP:0012224', 'Circulating immune complexes', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260864, 'HP:0012224', 'Circulating immune complexes', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260865, 'HP:0012224', 'Circulating immune complexes', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260866, 'HP:0012224', 'Circulating immune complexes', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260867, 'HP:0012224', 'Circulating immune complexes', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260868, 'HP:0012224', 'Circulating immune complexes', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260869, 'HP:0012224', 'Circulating immune complexes', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260870, 'HP:0012224', 'Circulating immune complexes', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260871, 'HP:0012224', 'Circulating immune complexes', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260872, 'HP:0012224', 'Circulating immune complexes', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260873, 'HP:0012224', 'Circulating immune complexes', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260874, 'HP:0012224', 'Circulating immune complexes', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260875, 'HP:0012224', 'Circulating immune complexes', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260876, 'HP:0012224', 'Circulating immune complexes', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260877, 'HP:0012224', 'Circulating immune complexes', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260878, 'HP:0012224', 'Circulating immune complexes', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260879, 'HP:0012224', 'Circulating immune complexes', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260880, 'HP:0012224', 'Circulating immune complexes', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260881, 'HP:0012224', 'Circulating immune complexes', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260882, 'HP:0012224', 'Circulating immune complexes', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260883, 'HP:0012224', 'Circulating immune complexes', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260884, 'HP:0012224', 'Circulating immune complexes', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260885, 'HP:0012224', 'Circulating immune complexes', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260886, 'HP:0012224', 'Circulating immune complexes', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260887, 'HP:0012224', 'Circulating immune complexes', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260888, 'HP:0012224', 'Circulating immune complexes', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260889, 'HP:0012224', 'Circulating immune complexes', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260890, 'HP:0012224', 'Circulating immune complexes', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260891, 'HP:0012224', 'Circulating immune complexes', 'MP:0013479', 'scleritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260892, 'HP:0012224', 'Circulating immune complexes', 'MP:0002409', 'decreased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260893, 'HP:0012224', 'Circulating immune complexes', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260894, 'HP:0012224', 'Circulating immune complexes', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260895, 'HP:0012224', 'Circulating immune complexes', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260896, 'HP:0012224', 'Circulating immune complexes', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260897, 'HP:0012224', 'Circulating immune complexes', 'MP:0002254', 'reproductive system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260898, 'HP:0012224', 'Circulating immune complexes', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260899, 'HP:0012224', 'Circulating immune complexes', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260900, 'HP:0012224', 'Circulating immune complexes', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260901, 'HP:0012224', 'Circulating immune complexes', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260902, 'HP:0012224', 'Circulating immune complexes', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260903, 'HP:0012224', 'Circulating immune complexes', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260904, 'HP:0012224', 'Circulating immune complexes', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260905, 'HP:0012224', 'Circulating immune complexes', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260906, 'HP:0012224', 'Circulating immune complexes', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260907, 'HP:0012224', 'Circulating immune complexes', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260908, 'HP:0012224', 'Circulating immune complexes', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260909, 'HP:0012224', 'Circulating immune complexes', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260910, 'HP:0012224', 'Circulating immune complexes', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260911, 'HP:0012224', 'Circulating immune complexes', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260912, 'HP:0012224', 'Circulating immune complexes', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260913, 'HP:0012224', 'Circulating immune complexes', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260914, 'HP:0012224', 'Circulating immune complexes', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260915, 'HP:0012224', 'Circulating immune complexes', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260916, 'HP:0012224', 'Circulating immune complexes', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260917, 'HP:0012224', 'Circulating immune complexes', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260918, 'HP:0012224', 'Circulating immune complexes', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260919, 'HP:0012224', 'Circulating immune complexes', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260920, 'HP:0012224', 'Circulating immune complexes', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260921, 'HP:0012224', 'Circulating immune complexes', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260922, 'HP:0012224', 'Circulating immune complexes', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260923, 'HP:0012224', 'Circulating immune complexes', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260924, 'HP:0012224', 'Circulating immune complexes', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260925, 'HP:0012224', 'Circulating immune complexes', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260926, 'HP:0012224', 'Circulating immune complexes', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260927, 'HP:0012224', 'Circulating immune complexes', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260928, 'HP:0012224', 'Circulating immune complexes', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260929, 'HP:0012224', 'Circulating immune complexes', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260930, 'HP:0012224', 'Circulating immune complexes', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260931, 'HP:0012224', 'Circulating immune complexes', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260932, 'HP:0012224', 'Circulating immune complexes', 'MP:0008681', 'increased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260933, 'HP:0012224', 'Circulating immune complexes', 'MP:0002935', 'chronic joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260934, 'HP:0012224', 'Circulating immune complexes', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260935, 'HP:0012224', 'Circulating immune complexes', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260936, 'HP:0012224', 'Circulating immune complexes', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260937, 'HP:0012224', 'Circulating immune complexes', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260938, 'HP:0012224', 'Circulating immune complexes', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260939, 'HP:0012224', 'Circulating immune complexes', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260940, 'HP:0012224', 'Circulating immune complexes', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260941, 'HP:0012224', 'Circulating immune complexes', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260942, 'HP:0012224', 'Circulating immune complexes', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260943, 'HP:0012224', 'Circulating immune complexes', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260944, 'HP:0012224', 'Circulating immune complexes', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260945, 'HP:0012224', 'Circulating immune complexes', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260946, 'HP:0012224', 'Circulating immune complexes', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260947, 'HP:0012224', 'Circulating immune complexes', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260948, 'HP:0012224', 'Circulating immune complexes', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260949, 'HP:0012224', 'Circulating immune complexes', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260950, 'HP:0012224', 'Circulating immune complexes', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260951, 'HP:0012224', 'Circulating immune complexes', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260952, 'HP:0012224', 'Circulating immune complexes', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260953, 'HP:0012224', 'Circulating immune complexes', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260954, 'HP:0012224', 'Circulating immune complexes', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260955, 'HP:0012224', 'Circulating immune complexes', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260956, 'HP:0012224', 'Circulating immune complexes', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260957, 'HP:0012224', 'Circulating immune complexes', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260958, 'HP:0012224', 'Circulating immune complexes', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260959, 'HP:0012224', 'Circulating immune complexes', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260960, 'HP:0012224', 'Circulating immune complexes', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260961, 'HP:0012224', 'Circulating immune complexes', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260962, 'HP:0012224', 'Circulating immune complexes', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260963, 'HP:0012224', 'Circulating immune complexes', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260964, 'HP:0012224', 'Circulating immune complexes', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260965, 'HP:0012224', 'Circulating immune complexes', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260966, 'HP:0012224', 'Circulating immune complexes', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260967, 'HP:0012224', 'Circulating immune complexes', 'MP:0008684', 'increased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260968, 'HP:0012224', 'Circulating immune complexes', 'MP:0030822', 'sacroiliac joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260969, 'HP:0012224', 'Circulating immune complexes', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260970, 'HP:0012224', 'Circulating immune complexes', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260971, 'HP:0012224', 'Circulating immune complexes', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260972, 'HP:0012224', 'Circulating immune complexes', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260973, 'HP:0012224', 'Circulating immune complexes', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260974, 'HP:0012224', 'Circulating immune complexes', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260975, 'HP:0012224', 'Circulating immune complexes', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260976, 'HP:0012224', 'Circulating immune complexes', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260977, 'HP:0012224', 'Circulating immune complexes', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260978, 'HP:0012224', 'Circulating immune complexes', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260979, 'HP:0012224', 'Circulating immune complexes', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260980, 'HP:0012224', 'Circulating immune complexes', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260981, 'HP:0012224', 'Circulating immune complexes', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260982, 'HP:0012224', 'Circulating immune complexes', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260983, 'HP:0012224', 'Circulating immune complexes', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260984, 'HP:0012224', 'Circulating immune complexes', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260985, 'HP:0012224', 'Circulating immune complexes', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260986, 'HP:0012224', 'Circulating immune complexes', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260987, 'HP:0012224', 'Circulating immune complexes', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260988, 'HP:0012224', 'Circulating immune complexes', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260989, 'HP:0012224', 'Circulating immune complexes', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260990, 'HP:0012224', 'Circulating immune complexes', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260991, 'HP:0012224', 'Circulating immune complexes', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260992, 'HP:0012224', 'Circulating immune complexes', 'MP:0020001', 'decreased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260993, 'HP:0012224', 'Circulating immune complexes', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260994, 'HP:0012224', 'Circulating immune complexes', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260995, 'HP:0012224', 'Circulating immune complexes', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260996, 'HP:0012224', 'Circulating immune complexes', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260997, 'HP:0012224', 'Circulating immune complexes', 'MP:0008568', 'abnormal interleukin secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(260998, 'HP:0012224', 'Circulating immune complexes', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(260999, 'HP:0012224', 'Circulating immune complexes', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261000, 'HP:0012224', 'Circulating immune complexes', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261001, 'HP:0012224', 'Circulating immune complexes', 'MP:0011717', 'increased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261002, 'HP:0012224', 'Circulating immune complexes', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261003, 'HP:0012224', 'Circulating immune complexes', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261004, 'HP:0012224', 'Circulating immune complexes', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261005, 'HP:0012224', 'Circulating immune complexes', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261006, 'HP:0012224', 'Circulating immune complexes', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261007, 'HP:0012224', 'Circulating immune complexes', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261008, 'HP:0012224', 'Circulating immune complexes', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261009, 'HP:0012224', 'Circulating immune complexes', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261010, 'HP:0012224', 'Circulating immune complexes', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261011, 'HP:0012224', 'Circulating immune complexes', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261012, 'HP:0012224', 'Circulating immune complexes', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261013, 'HP:0012224', 'Circulating immune complexes', 'MP:0008666', 'increased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261014, 'HP:0012224', 'Circulating immune complexes', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261015, 'HP:0012224', 'Circulating immune complexes', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261016, 'HP:0012224', 'Circulating immune complexes', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261017, 'HP:0012224', 'Circulating immune complexes', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261018, 'HP:0012224', 'Circulating immune complexes', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261019, 'HP:0012224', 'Circulating immune complexes', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261020, 'HP:0012224', 'Circulating immune complexes', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261021, 'HP:0012224', 'Circulating immune complexes', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261022, 'HP:0012224', 'Circulating immune complexes', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261023, 'HP:0012224', 'Circulating immune complexes', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261024, 'HP:0012224', 'Circulating immune complexes', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261025, 'HP:0012224', 'Circulating immune complexes', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261026, 'HP:0012224', 'Circulating immune complexes', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261027, 'HP:0012224', 'Circulating immune complexes', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261028, 'HP:0012224', 'Circulating immune complexes', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261029, 'HP:0012224', 'Circulating immune complexes', 'MP:0001872', 'sinus inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261030, 'HP:0012224', 'Circulating immune complexes', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261031, 'HP:0012224', 'Circulating immune complexes', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261032, 'HP:0012224', 'Circulating immune complexes', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261033, 'HP:0012224', 'Circulating immune complexes', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261034, 'HP:0012224', 'Circulating immune complexes', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261035, 'HP:0012224', 'Circulating immune complexes', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261036, 'HP:0012224', 'Circulating immune complexes', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261037, 'HP:0012224', 'Circulating immune complexes', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261038, 'HP:0012224', 'Circulating immune complexes', 'MP:0010539', 'decreased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261039, 'HP:0012224', 'Circulating immune complexes', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261040, 'HP:0012224', 'Circulating immune complexes', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261041, 'HP:0012224', 'Circulating immune complexes', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261042, 'HP:0012224', 'Circulating immune complexes', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261043, 'HP:0012224', 'Circulating immune complexes', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261044, 'HP:0012224', 'Circulating immune complexes', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261045, 'HP:0012224', 'Circulating immune complexes', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261046, 'HP:0012224', 'Circulating immune complexes', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261047, 'HP:0012224', 'Circulating immune complexes', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261048, 'HP:0012224', 'Circulating immune complexes', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261049, 'HP:0012224', 'Circulating immune complexes', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261050, 'HP:0012224', 'Circulating immune complexes', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261051, 'HP:0012224', 'Circulating immune complexes', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261052, 'HP:0012224', 'Circulating immune complexes', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261053, 'HP:0012224', 'Circulating immune complexes', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261054, 'HP:0012224', 'Circulating immune complexes', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261055, 'HP:0012224', 'Circulating immune complexes', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261056, 'HP:0012224', 'Circulating immune complexes', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261057, 'HP:0012224', 'Circulating immune complexes', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261058, 'HP:0012224', 'Circulating immune complexes', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261059, 'HP:0012224', 'Circulating immune complexes', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261060, 'HP:0012224', 'Circulating immune complexes', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261061, 'HP:0012224', 'Circulating immune complexes', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261062, 'HP:0012224', 'Circulating immune complexes', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261063, 'HP:0012224', 'Circulating immune complexes', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261064, 'HP:0012224', 'Circulating immune complexes', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261065, 'HP:0012224', 'Circulating immune complexes', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261066, 'HP:0012224', 'Circulating immune complexes', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261067, 'HP:0012224', 'Circulating immune complexes', 'MP:0008744', 'abnormal B cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261068, 'HP:0012224', 'Circulating immune complexes', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261069, 'HP:0012224', 'Circulating immune complexes', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261070, 'HP:0012224', 'Circulating immune complexes', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261071, 'HP:0012224', 'Circulating immune complexes', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261072, 'HP:0012224', 'Circulating immune complexes', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261073, 'HP:0012224', 'Circulating immune complexes', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261074, 'HP:0012224', 'Circulating immune complexes', 'MP:0010211', 'abnormal acute phase protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261075, 'HP:0012224', 'Circulating immune complexes', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261076, 'HP:0012224', 'Circulating immune complexes', 'MP:0003777', 'lip inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261077, 'HP:0012224', 'Circulating immune complexes', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261078, 'HP:0012224', 'Circulating immune complexes', 'MP:0002498', 'abnormal acute inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261079, 'HP:0012224', 'Circulating immune complexes', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261080, 'HP:0012224', 'Circulating immune complexes', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261081, 'HP:0012224', 'Circulating immune complexes', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261082, 'HP:0012224', 'Circulating immune complexes', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261083, 'HP:0012224', 'Circulating immune complexes', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261084, 'HP:0012224', 'Circulating immune complexes', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261085, 'HP:0012224', 'Circulating immune complexes', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261086, 'HP:0012224', 'Circulating immune complexes', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261087, 'HP:0012224', 'Circulating immune complexes', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261088, 'HP:0012224', 'Circulating immune complexes', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261089, 'HP:0012224', 'Circulating immune complexes', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261090, 'HP:0012224', 'Circulating immune complexes', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261091, 'HP:0012224', 'Circulating immune complexes', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261092, 'HP:0012224', 'Circulating immune complexes', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261093, 'HP:0012224', 'Circulating immune complexes', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261094, 'HP:0012224', 'Circulating immune complexes', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261095, 'HP:0012224', 'Circulating immune complexes', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261096, 'HP:0012224', 'Circulating immune complexes', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261097, 'HP:0012224', 'Circulating immune complexes', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261098, 'HP:0012224', 'Circulating immune complexes', 'MP:0004031', 'insulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261099, 'HP:0012224', 'Circulating immune complexes', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261100, 'HP:0012224', 'Circulating immune complexes', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261101, 'HP:0012224', 'Circulating immune complexes', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261102, 'HP:0012224', 'Circulating immune complexes', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261103, 'HP:0012224', 'Circulating immune complexes', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261104, 'HP:0012224', 'Circulating immune complexes', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261105, 'HP:0012224', 'Circulating immune complexes', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261106, 'HP:0012224', 'Circulating immune complexes', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261107, 'HP:0012224', 'Circulating immune complexes', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261108, 'HP:0012224', 'Circulating immune complexes', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261109, 'HP:0012224', 'Circulating immune complexes', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261110, 'HP:0012224', 'Circulating immune complexes', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261111, 'HP:0012224', 'Circulating immune complexes', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261112, 'HP:0012224', 'Circulating immune complexes', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261113, 'HP:0012224', 'Circulating immune complexes', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261114, 'HP:0012224', 'Circulating immune complexes', 'MP:0001852', 'conjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261115, 'HP:0012224', 'Circulating immune complexes', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261116, 'HP:0012224', 'Circulating immune complexes', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261117, 'HP:0012224', 'Circulating immune complexes', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261118, 'HP:0012224', 'Circulating immune complexes', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261119, 'HP:0012224', 'Circulating immune complexes', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261120, 'HP:0012224', 'Circulating immune complexes', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261121, 'HP:0012224', 'Circulating immune complexes', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261122, 'HP:0012224', 'Circulating immune complexes', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261123, 'HP:0012224', 'Circulating immune complexes', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261124, 'HP:0012224', 'Circulating immune complexes', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261125, 'HP:0012224', 'Circulating immune complexes', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261126, 'HP:0012224', 'Circulating immune complexes', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261127, 'HP:0012224', 'Circulating immune complexes', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261128, 'HP:0012224', 'Circulating immune complexes', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261129, 'HP:0012224', 'Circulating immune complexes', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261130, 'HP:0012224', 'Circulating immune complexes', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261131, 'HP:0012224', 'Circulating immune complexes', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261132, 'HP:0012224', 'Circulating immune complexes', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261133, 'HP:0012224', 'Circulating immune complexes', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261134, 'HP:0012224', 'Circulating immune complexes', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261135, 'HP:0012224', 'Circulating immune complexes', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261136, 'HP:0012224', 'Circulating immune complexes', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261137, 'HP:0012224', 'Circulating immune complexes', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261138, 'HP:0012224', 'Circulating immune complexes', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261139, 'HP:0012224', 'Circulating immune complexes', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261140, 'HP:0012224', 'Circulating immune complexes', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261141, 'HP:0012224', 'Circulating immune complexes', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261142, 'HP:0012224', 'Circulating immune complexes', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261143, 'HP:0012224', 'Circulating immune complexes', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261144, 'HP:0012224', 'Circulating immune complexes', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261145, 'HP:0012224', 'Circulating immune complexes', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261146, 'HP:0012224', 'Circulating immune complexes', 'MP:0008565', 'decreased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261147, 'HP:0012224', 'Circulating immune complexes', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261148, 'HP:0012224', 'Circulating immune complexes', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261149, 'HP:0012224', 'Circulating immune complexes', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261150, 'HP:0012224', 'Circulating immune complexes', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261151, 'HP:0012224', 'Circulating immune complexes', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261152, 'HP:0012224', 'Circulating immune complexes', 'MP:0013942', 'enthesitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261153, 'HP:0012224', 'Circulating immune complexes', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261154, 'HP:0012224', 'Circulating immune complexes', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261155, 'HP:0012224', 'Circulating immune complexes', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261156, 'HP:0012224', 'Circulating immune complexes', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261157, 'HP:0012224', 'Circulating immune complexes', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261158, 'HP:0012224', 'Circulating immune complexes', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261159, 'HP:0012224', 'Circulating immune complexes', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261160, 'HP:0012224', 'Circulating immune complexes', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261161, 'HP:0012224', 'Circulating immune complexes', 'MP:0005043', 'defective assembly of class II molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261162, 'HP:0012224', 'Circulating immune complexes', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261163, 'HP:0012224', 'Circulating immune complexes', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261164, 'HP:0012224', 'Circulating immune complexes', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261165, 'HP:0012224', 'Circulating immune complexes', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261166, 'HP:0012224', 'Circulating immune complexes', 'MP:0003665', 'endophthalmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261167, 'HP:0012224', 'Circulating immune complexes', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261168, 'HP:0012224', 'Circulating immune complexes', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261169, 'HP:0012224', 'Circulating immune complexes', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261170, 'HP:0012224', 'Circulating immune complexes', 'MP:0031224', 'abnormal CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261171, 'HP:0012224', 'Circulating immune complexes', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261172, 'HP:0012224', 'Circulating immune complexes', 'MP:0008702', 'increased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261173, 'HP:0012224', 'Circulating immune complexes', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261174, 'HP:0012224', 'Circulating immune complexes', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261175, 'HP:0012224', 'Circulating immune complexes', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261176, 'HP:0012224', 'Circulating immune complexes', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261177, 'HP:0012224', 'Circulating immune complexes', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261178, 'HP:0012224', 'Circulating immune complexes', 'MP:0031055', 'bronchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261179, 'HP:0012224', 'Circulating immune complexes', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261180, 'HP:0012224', 'Circulating immune complexes', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261181, 'HP:0012224', 'Circulating immune complexes', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261182, 'HP:0012224', 'Circulating immune complexes', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261183, 'HP:0012224', 'Circulating immune complexes', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261184, 'HP:0012224', 'Circulating immune complexes', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261185, 'HP:0012224', 'Circulating immune complexes', 'MP:0031248', 'increased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261186, 'HP:0012224', 'Circulating immune complexes', 'MP:0005251', 'blepharitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261187, 'HP:0012224', 'Circulating immune complexes', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261188, 'HP:0012224', 'Circulating immune complexes', 'MP:0011763', 'urethritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261189, 'HP:0012224', 'Circulating immune complexes', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261190, 'HP:0012224', 'Circulating immune complexes', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261191, 'HP:0012224', 'Circulating immune complexes', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261192, 'HP:0012224', 'Circulating immune complexes', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261193, 'HP:0012224', 'Circulating immune complexes', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261194, 'HP:0012224', 'Circulating immune complexes', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261195, 'HP:0012224', 'Circulating immune complexes', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261196, 'HP:0012224', 'Circulating immune complexes', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261197, 'HP:0012224', 'Circulating immune complexes', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261198, 'HP:0012224', 'Circulating immune complexes', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261199, 'HP:0012224', 'Circulating immune complexes', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261200, 'HP:0012224', 'Circulating immune complexes', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261201, 'HP:0012224', 'Circulating immune complexes', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261202, 'HP:0012224', 'Circulating immune complexes', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261203, 'HP:0012224', 'Circulating immune complexes', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261204, 'HP:0012224', 'Circulating immune complexes', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261205, 'HP:0012224', 'Circulating immune complexes', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261206, 'HP:0012224', 'Circulating immune complexes', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261207, 'HP:0012224', 'Circulating immune complexes', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261208, 'HP:0012224', 'Circulating immune complexes', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261209, 'HP:0012224', 'Circulating immune complexes', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261210, 'HP:0012224', 'Circulating immune complexes', 'MP:0003725', 'increased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261211, 'HP:0012224', 'Circulating immune complexes', 'MP:0003278', 'esophageal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261212, 'HP:0012224', 'Circulating immune complexes', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261213, 'HP:0012224', 'Circulating immune complexes', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261214, 'HP:0012224', 'Circulating immune complexes', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261215, 'HP:0012224', 'Circulating immune complexes', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261216, 'HP:0012224', 'Circulating immune complexes', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261217, 'HP:0012224', 'Circulating immune complexes', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261218, 'HP:0012224', 'Circulating immune complexes', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261219, 'HP:0012224', 'Circulating immune complexes', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261220, 'HP:0012224', 'Circulating immune complexes', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261221, 'HP:0012224', 'Circulating immune complexes', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261222, 'HP:0012224', 'Circulating immune complexes', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261223, 'HP:0012224', 'Circulating immune complexes', 'MP:0001869', 'pancreas inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261224, 'HP:0012224', 'Circulating immune complexes', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261225, 'HP:0012224', 'Circulating immune complexes', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261226, 'HP:0012224', 'Circulating immune complexes', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261227, 'HP:0012224', 'Circulating immune complexes', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261228, 'HP:0012224', 'Circulating immune complexes', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261229, 'HP:0012224', 'Circulating immune complexes', 'MP:0012553', 'decreased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261230, 'HP:0012224', 'Circulating immune complexes', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261231, 'HP:0012224', 'Circulating immune complexes', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261232, 'HP:0012224', 'Circulating immune complexes', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261233, 'HP:0012224', 'Circulating immune complexes', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261234, 'HP:0012224', 'Circulating immune complexes', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261235, 'HP:0012224', 'Circulating immune complexes', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261236, 'HP:0012224', 'Circulating immune complexes', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261237, 'HP:0012224', 'Circulating immune complexes', 'MP:0030130', 'gum inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261238, 'HP:0012224', 'Circulating immune complexes', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261239, 'HP:0012224', 'Circulating immune complexes', 'MP:0008663', 'increased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261240, 'HP:0012224', 'Circulating immune complexes', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261241, 'HP:0012224', 'Circulating immune complexes', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261242, 'HP:0012224', 'Circulating immune complexes', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261243, 'HP:0012224', 'Circulating immune complexes', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261244, 'HP:0012224', 'Circulating immune complexes', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261245, 'HP:0012224', 'Circulating immune complexes', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261246, 'HP:0012224', 'Circulating immune complexes', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261247, 'HP:0012224', 'Circulating immune complexes', 'MP:0004752', 'decreased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261248, 'HP:0012224', 'Circulating immune complexes', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261249, 'HP:0012224', 'Circulating immune complexes', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261250, 'HP:0012224', 'Circulating immune complexes', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261251, 'HP:0012224', 'Circulating immune complexes', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261252, 'HP:0012224', 'Circulating immune complexes', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261253, 'HP:0012224', 'Circulating immune complexes', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261254, 'HP:0012224', 'Circulating immune complexes', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261255, 'HP:0012224', 'Circulating immune complexes', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261256, 'HP:0012224', 'Circulating immune complexes', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261257, 'HP:0012224', 'Circulating immune complexes', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261258, 'HP:0012224', 'Circulating immune complexes', 'MP:0012565', 'perivasculitis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261259, 'HP:0012224', 'Circulating immune complexes', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261260, 'HP:0012224', 'Circulating immune complexes', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261261, 'HP:0012224', 'Circulating immune complexes', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261262, 'HP:0012224', 'Circulating immune complexes', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261263, 'HP:0012224', 'Circulating immune complexes', 'MP:0001861', 'lung inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261264, 'HP:0012224', 'Circulating immune complexes', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261265, 'HP:0012224', 'Circulating immune complexes', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261266, 'HP:0012224', 'Circulating immune complexes', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261267, 'HP:0012224', 'Circulating immune complexes', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261268, 'HP:0012224', 'Circulating immune complexes', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261269, 'HP:0012224', 'Circulating immune complexes', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261270, 'HP:0012224', 'Circulating immune complexes', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261271, 'HP:0012224', 'Circulating immune complexes', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261272, 'HP:0012224', 'Circulating immune complexes', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261273, 'HP:0012224', 'Circulating immune complexes', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261274, 'HP:0012224', 'Circulating immune complexes', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261275, 'HP:0012224', 'Circulating immune complexes', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261276, 'HP:0012224', 'Circulating immune complexes', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261277, 'HP:0012224', 'Circulating immune complexes', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261278, 'HP:0012224', 'Circulating immune complexes', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261279, 'HP:0012224', 'Circulating immune complexes', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261280, 'HP:0012224', 'Circulating immune complexes', 'MP:0003303', 'peritoneal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261281, 'HP:0012224', 'Circulating immune complexes', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261282, 'HP:0012224', 'Circulating immune complexes', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261283, 'HP:0012224', 'Circulating immune complexes', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261284, 'HP:0012224', 'Circulating immune complexes', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261285, 'HP:0012224', 'Circulating immune complexes', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261286, 'HP:0012224', 'Circulating immune complexes', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261287, 'HP:0012224', 'Circulating immune complexes', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261288, 'HP:0012224', 'Circulating immune complexes', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261289, 'HP:0012224', 'Circulating immune complexes', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261290, 'HP:0012224', 'Circulating immune complexes', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261291, 'HP:0012224', 'Circulating immune complexes', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261292, 'HP:0012224', 'Circulating immune complexes', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261293, 'HP:0012224', 'Circulating immune complexes', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261294, 'HP:0012224', 'Circulating immune complexes', 'MP:0008703', 'decreased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261295, 'HP:0012224', 'Circulating immune complexes', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261296, 'HP:0012224', 'Circulating immune complexes', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261297, 'HP:0012224', 'Circulating immune complexes', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261298, 'HP:0012224', 'Circulating immune complexes', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261299, 'HP:0012224', 'Circulating immune complexes', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261300, 'HP:0012224', 'Circulating immune complexes', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261301, 'HP:0012224', 'Circulating immune complexes', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261302, 'HP:0012224', 'Circulating immune complexes', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261303, 'HP:0012224', 'Circulating immune complexes', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261304, 'HP:0012224', 'Circulating immune complexes', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261305, 'HP:0012224', 'Circulating immune complexes', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261306, 'HP:0012224', 'Circulating immune complexes', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261307, 'HP:0012224', 'Circulating immune complexes', 'MP:0002473', 'impaired complement classical pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261308, 'HP:0012224', 'Circulating immune complexes', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261309, 'HP:0012224', 'Circulating immune complexes', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261310, 'HP:0012224', 'Circulating immune complexes', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261311, 'HP:0012224', 'Circulating immune complexes', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261312, 'HP:0012224', 'Circulating immune complexes', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261313, 'HP:0012224', 'Circulating immune complexes', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261314, 'HP:0012224', 'Circulating immune complexes', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261315, 'HP:0012224', 'Circulating immune complexes', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261316, 'HP:0012224', 'Circulating immune complexes', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261317, 'HP:0012224', 'Circulating immune complexes', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261318, 'HP:0012224', 'Circulating immune complexes', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261319, 'HP:0012224', 'Circulating immune complexes', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261320, 'HP:0012224', 'Circulating immune complexes', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261321, 'HP:0012224', 'Circulating immune complexes', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261322, 'HP:0012224', 'Circulating immune complexes', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261323, 'HP:0012224', 'Circulating immune complexes', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261324, 'HP:0012224', 'Circulating immune complexes', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261325, 'HP:0012224', 'Circulating immune complexes', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261326, 'HP:0012224', 'Circulating immune complexes', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261327, 'HP:0012224', 'Circulating immune complexes', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261328, 'HP:0012224', 'Circulating immune complexes', 'MP:0003340', 'acute pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261329, 'HP:0012224', 'Circulating immune complexes', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261330, 'HP:0012224', 'Circulating immune complexes', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261331, 'HP:0012224', 'Circulating immune complexes', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261332, 'HP:0012224', 'Circulating immune complexes', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261333, 'HP:0012224', 'Circulating immune complexes', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261334, 'HP:0012224', 'Circulating immune complexes', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261335, 'HP:0012224', 'Circulating immune complexes', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261336, 'HP:0012224', 'Circulating immune complexes', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261337, 'HP:0012224', 'Circulating immune complexes', 'MP:0008751', 'abnormal interleukin level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261338, 'HP:0012224', 'Circulating immune complexes', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261339, 'HP:0012224', 'Circulating immune complexes', 'MP:0003009', 'abnormal cytokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261340, 'HP:0012224', 'Circulating immune complexes', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261341, 'HP:0012224', 'Circulating immune complexes', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261342, 'HP:0012224', 'Circulating immune complexes', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261343, 'HP:0012224', 'Circulating immune complexes', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261344, 'HP:0012224', 'Circulating immune complexes', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261345, 'HP:0012224', 'Circulating immune complexes', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261346, 'HP:0012224', 'Circulating immune complexes', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261347, 'HP:0012224', 'Circulating immune complexes', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261348, 'HP:0012224', 'Circulating immune complexes', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261349, 'HP:0012224', 'Circulating immune complexes', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261350, 'HP:0012224', 'Circulating immune complexes', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261351, 'HP:0012224', 'Circulating immune complexes', 'MP:0005190', 'osteomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261352, 'HP:0012224', 'Circulating immune complexes', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261353, 'HP:0012224', 'Circulating immune complexes', 'MP:0008672', 'increased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261354, 'HP:0012224', 'Circulating immune complexes', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261355, 'HP:0012224', 'Circulating immune complexes', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261356, 'HP:0012224', 'Circulating immune complexes', 'MP:0001790', 'abnormal immune system physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261357, 'HP:0012224', 'Circulating immune complexes', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261358, 'HP:0012224', 'Circulating immune complexes', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261359, 'HP:0012224', 'Circulating immune complexes', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261360, 'HP:0012224', 'Circulating immune complexes', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261361, 'HP:0012224', 'Circulating immune complexes', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261362, 'HP:0012224', 'Circulating immune complexes', 'MP:0031226', 'increased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261363, 'HP:0012224', 'Circulating immune complexes', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261364, 'HP:0012224', 'Circulating immune complexes', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261365, 'HP:0012224', 'Circulating immune complexes', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261366, 'HP:0012224', 'Circulating immune complexes', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261367, 'HP:0012224', 'Circulating immune complexes', 'MP:0031125', 'aspiration pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261368, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000731', 'increased collagen deposition in the muscles', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261369, 'HP:0034045', 'Angulated muscle fibers', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.41935483870967744, 9.847813860716615, 2.0321733177078527, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261370, 'HP:0034045', 'Angulated muscle fibers', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261371, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000767', 'abnormal smooth muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261372, 'HP:0034045', 'Angulated muscle fibers', 'MP:0004817', 'abnormal skeletal muscle mass', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261373, 'HP:0034045', 'Angulated muscle fibers', 'MP:0031112', 'rhabdomyolysis', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261374, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000752', 'dystrophic muscle', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261375, 'HP:0034045', 'Angulated muscle fibers', 'MP:0003939', 'abnormal myotome morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261376, 'HP:0034045', 'Angulated muscle fibers', 'MP:0002108', 'abnormal muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261377, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000733', 'abnormal muscle development', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261378, 'HP:0034045', 'Angulated muscle fibers', 'MP:0004819', 'decreased skeletal muscle mass', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261379, 'HP:0034045', 'Angulated muscle fibers', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261380, 'HP:0034045', 'Angulated muscle fibers', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261381, 'HP:0034045', 'Angulated muscle fibers', 'MP:0004818', 'increased skeletal muscle mass', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261382, 'HP:0034045', 'Angulated muscle fibers', 'MP:0003084', 'abnormal skeletal muscle fiber morphology', 0.40540540540540543, 11.261372431069546, 2.136684641176373, 'UPHENO:0088180', 'abnormal cell of skeletal muscle morphology'),
(261383, 'HP:0034045', 'Angulated muscle fibers', 'MP:0009407', 'increased skeletal muscle fiber density', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261384, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000736', 'delayed muscle development', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(261385, 'HP:0034045', 'Angulated muscle fibers', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261386, 'HP:0034045', 'Angulated muscle fibers', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.48148148148148145, 9.847813860716615, 2.1775077513092125, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(261387, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0003941', 'abnormal skin development', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261388, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0009563', 'dyskeratosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261389, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0009931', 'abnormal skin appearance', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261390, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0011239', 'abnormal skin coloration', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261391, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0002060', 'abnormal skin morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261392, 'HP:0034697', 'Cutaneous telangiectasia', 'MP:0001191', 'abnormal skin condition', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261393, 'HP:0002682', 'Broad skull', 'MP:0000439', 'enlarged cranium', 0.41379310344827586, 7.173214147510782, 1.7228541852976313, 'UPHENO:0081566', 'abnormal skull morphology'),
(261394, 'HP:0002682', 'Broad skull', 'MP:0030282', 'broad supraoccipital bone', 0.41935483870967744, 9.252530554317739, 1.9697952833384178, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(261395, 'HP:0002682', 'Broad skull', 'MP:0030316', 'enlarged neurocranium', 0.41379310344827586, 7.173214147510782, 1.7228541852976313, 'UPHENO:0081566', 'abnormal skull morphology'),
(261396, 'HP:0002682', 'Broad skull', 'MP:0004421', 'enlarged parietal bone', 0.4098360655737705, 10.450642782231284, 2.0695531693065035, 'UPHENO:0002700', 'abnormal vault of skull'),
(261397, 'HP:0002682', 'Broad skull', 'MP:0004676', 'wide ribs', 0.40384615384615385, 9.252530554317739, 1.9330284213392313, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(261398, 'HP:0002682', 'Broad skull', 'MP:0030288', 'broad occipital bone', 0.41935483870967744, 9.252530554317739, 1.9697952833384178, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(261399, 'HP:0002682', 'Broad skull', 'MP:0000441', 'increased cranium width', 0.43333333333333335, 9.252530554317739, 2.0023560889289946, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(261400, 'HP:0002682', 'Broad skull', 'MP:0004386', 'enlarged interparietal bone', 0.4166666666666667, 10.450642782231284, 2.0867281788954615, 'UPHENO:0002700', 'abnormal vault of skull'),
(261401, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0013406', 'abnormal epidermal immune compartment', 0.45161290322580644, 8.592196926445304, 1.9698596394260721, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261402, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009563', 'dyskeratosis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261403, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261404, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0012078', 'abnormal tail ring morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261405, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001197', 'oily skin', 0.47058823529411764, 7.4735768925632104, 1.8753605949806604, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261406, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001243', 'abnormal dermal layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261407, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001192', 'scaly skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261408, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001230', 'epidermal desquamation', 0.45161290322580644, 8.592196926445304, 1.9698596394260721, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261409, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001874', 'acanthosis', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261410, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.42424242424242425, 8.592196926445304, 1.9092339965660212, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261411, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0000384', 'distorted hair follicle pattern', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261412, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001220', 'epidermal necrosis', 0.43902439024390244, 11.214829845132515, 2.21891501289446, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(261413, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001208', 'blistering', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261414, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0002897', 'blotchy skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261415, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009611', 'epidermis stratum spinosum hyperplasia', 0.4473684210526316, 8.592196926445304, 1.9605809272654648, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261416, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009931', 'abnormal skin appearance', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261417, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009599', 'thick epidermis stratum granulosum', 0.425, 8.592196926445304, 1.9109379094411347, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261418, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4375, 8.592196926445304, 1.9388362889423698, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261419, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009795', 'epidermal spongiosis', 0.42105263157894735, 7.4735768925632104, 1.7739135316923853, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261420, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009600', 'hypergranulosis', 0.4146341463414634, 8.592196926445304, 1.887489930514702, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261421, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0008816', 'petechiae', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261422, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009605', 'decreased keratohyalin granule number', 0.4117647058823529, 8.592196926445304, 1.8809474847270478, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261423, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001193', 'psoriasis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261424, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003652', 'abnormal skin turgor', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261425, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0008854', 'bleb', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261426, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009613', 'thin epidermis suprabasal layer', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261427, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009714', 'thin epidermis stratum basale', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261428, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003956', 'abnormal body size', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(261429, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003941', 'abnormal skin development', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261430, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003940', 'abnormal dermatome morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261431, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001198', 'tight skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261432, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0005421', 'loose skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261433, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001222', 'epidermal hyperplasia', 0.5, 11.214829845132515, 2.3679980833113565, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(261434, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0002655', 'abnormal keratinocyte morphology', 0.4594594594594595, 8.592196926445304, 1.9868986273571656, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261435, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009604', 'increased keratohyalin granule number', 0.4117647058823529, 8.592196926445304, 1.8809474847270478, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261436, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001209', 'spontaneous skin ulceration', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261437, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001219', 'thick epidermis', 0.47368421052631576, 11.214829845132515, 2.30484008585814, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(261438, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009601', 'epidermis stratum granulosum hyperplasia', 0.4473684210526316, 8.592196926445304, 1.9605809272654648, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261439, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003853', 'dry skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261440, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4375, 8.592196926445304, 1.9388362889423698, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261441, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003717', 'pallor', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261442, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261443, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001195', 'flaky skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261444, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001238', 'thin epidermis stratum spinosum', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261445, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0031094', 'organomegaly', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(261446, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0030584', 'skin atrophy', 0.45714285714285713, 7.4735768925632104, 1.8483755824353398, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261447, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001245', 'thick dermal layer', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261448, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0000367', 'abnormal coat/ hair morphology', 0.40625, 6.904974582545727, 1.67485698618097, 'UPHENO:0003811', 'abnormal skin of body'),
(261449, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009612', 'thick epidermis suprabasal layer', 0.425, 8.592196926445304, 1.9109379094411347, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261450, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261451, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001191', 'abnormal skin condition', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261452, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001235', 'disorganized suprabasal layer', 0.4857142857142857, 8.592196926445304, 2.0428785555790787, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261453, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001213', 'abnormal skin cell number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261454, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0011515', 'purpura', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261455, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003413', 'hair follicle degeneration', 0.425, 8.592196926445304, 1.9109379094411347, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261456, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0000381', 'enlarged hair follicles', 0.4146341463414634, 8.592196926445304, 1.887489930514702, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261457, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001199', 'thin skin', 0.43243243243243246, 7.4735768925632104, 1.7977255170414446, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261458, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009715', 'thick epidermis stratum basale', 0.425, 8.592196926445304, 1.9109379094411347, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261459, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009932', 'skin fibrosis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261460, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0000380', 'small hair follicles', 0.4146341463414634, 8.592196926445304, 1.887489930514702, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261461, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001218', 'thin epidermis', 0.4864864864864865, 11.214829845132515, 2.3357789210244846, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(261462, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003196', 'calcified skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261463, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009474', 'thick epidermis stratum spinosum', 0.425, 8.592196926445304, 1.9109379094411347, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261464, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009827', 'skin detachment', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261465, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001221', 'epidermal atrophy', 0.47368421052631576, 11.214829845132515, 2.30484008585814, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(261466, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0011160', 'dermal-epidermal separation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261467, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0002582', 'disorganized extraembryonic tissue', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(261468, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001215', 'skin hypoplasia', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261469, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009441', 'delayed skin barrier formation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261470, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4375, 8.592196926445304, 1.9388362889423698, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261471, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0004971', 'dermal hyperplasia', 0.43243243243243246, 7.4735768925632104, 1.7977255170414446, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261472, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0031103', 'skin rash', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261473, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001196', 'shiny skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261474, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4375, 8.592196926445304, 1.9388362889423698, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261475, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0002060', 'abnormal skin morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261476, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0002095', 'abnormal skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261477, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001200', 'thick skin', 0.42105263157894735, 7.4735768925632104, 1.7739135316923853, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261478, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0011004', 'abnormal epidermal stem cell morphology', 0.4594594594594595, 8.592196926445304, 1.9868986273571656, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261479, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4375, 8.592196926445304, 1.9388362889423698, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261480, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001214', 'skin hyperplasia', 0.43243243243243246, 7.4735768925632104, 1.7977255170414446, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261481, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009606', 'increased keratohyalin granule size', 0.4117647058823529, 8.592196926445304, 1.8809474847270478, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261482, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009598', 'thin epidermis stratum granulosum', 0.4358974358974359, 8.592196926445304, 1.9352820489435998, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261483, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001211', 'wrinkled skin', 0.48484848484848486, 7.4735768925632104, 1.9035630887254356, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261484, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261485, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001190', 'reddish skin', 0.4444444444444444, 7.4735768925632104, 1.8225229024701153, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261486, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001201', 'translucent skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261487, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001210', 'skin ridges', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261488, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001244', 'thin dermal layer', 0.42105263157894735, 7.4735768925632104, 1.7739135316923853, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261489, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0003653', 'decreased skin turgor', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261490, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0011239', 'abnormal skin coloration', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261491, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001786', 'skin edema', 0.43243243243243246, 7.4735768925632104, 1.7977255170414446, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261492, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0008856', 'fetal bleb', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261493, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0004241', 'acantholysis', 0.42424242424242425, 8.592196926445304, 1.9092339965660212, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261494, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001212', 'skin lesions', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261495, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.42424242424242425, 7.4735768925632104, 1.7806202230299364, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(261496, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0009607', 'decreased keratohyalin granule size', 0.4117647058823529, 8.592196926445304, 1.8809474847270478, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261497, 'HP:0034702', 'Abnormal keratinocyte morphology', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4666666666666667, 8.592196926445304, 2.002421508825704, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(261498, 'HP:0005765', 'Sacral meningocele', 'MP:0031313', 'spondylolisthesis', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261499, 'HP:0005765', 'Sacral meningocele', 'MP:0010113', 'abnormal sacrum morphology', 0.4444444444444444, 12.906707549770184, 2.3950604306707013, 'UPHENO:0087374', 'abnormal fused sacrum morphology'),
(261500, 'HP:0005765', 'Sacral meningocele', 'MP:0000160', 'kyphosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261501, 'HP:0005765', 'Sacral meningocele', 'MP:0000162', 'lordosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261502, 'HP:0005765', 'Sacral meningocele', 'MP:0000137', 'abnormal vertebrae morphology', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261503, 'HP:0005765', 'Sacral meningocele', 'MP:0006322', 'abnormal perichondrium morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(261504, 'HP:0005765', 'Sacral meningocele', 'MP:0004174', 'abnormal spine curvature', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261505, 'HP:0005765', 'Sacral meningocele', 'MP:0004669', 'enlarged vertebral body', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261506, 'HP:0005765', 'Sacral meningocele', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.41025641025641024, 8.557298718460714, 1.87368264488079, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261507, 'HP:0005765', 'Sacral meningocele', 'MP:0004703', 'abnormal vertebral column morphology', 0.42857142857142855, 8.557298718460714, 1.9150492778211121, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261508, 'HP:0005765', 'Sacral meningocele', 'MP:0021136', 'abnormal vertebrae shape', 0.4186046511627907, 8.557298718460714, 1.8926502701072492, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261509, 'HP:0005765', 'Sacral meningocele', 'MP:0004610', 'small vertebrae', 0.42857142857142855, 8.557298718460714, 1.9150492778211121, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261510, 'HP:0005765', 'Sacral meningocele', 'MP:0008771', 'elongated vertebral column', 0.4186046511627907, 8.557298718460714, 1.8926502701072492, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261511, 'HP:0005765', 'Sacral meningocele', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261512, 'HP:0005765', 'Sacral meningocele', 'MP:0004704', 'short vertebral column', 0.4186046511627907, 8.557298718460714, 1.8926502701072492, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261513, 'HP:0005765', 'Sacral meningocele', 'MP:0000161', 'scoliosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261514, 'HP:0005765', 'Sacral meningocele', 'MP:0031312', 'spondylolysis', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(261515, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0012021', 'abnormal melanocyte number', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(261516, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0003141', 'cardiac fibrosis', 0.4117647058823529, 7.506484928906078, 1.758097141503087, 'UPHENO:0076810', 'abnormal heart morphology'),
(261517, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0012022', 'increased melanocyte number', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261518, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0000716', 'abnormal immune system cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261519, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0003902', 'abnormal cell mass', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(261520, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0014239', 'abnormal intracellular organelle morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261521, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0005406', 'abnormal heart size', 0.4117647058823529, 7.506484928906078, 1.758097141503087, 'UPHENO:0076810', 'abnormal heart morphology'),
(261522, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0012023', 'decreased melanocyte number', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261523, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0003950', 'abnormal plasma membrane morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261524, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0009840', 'abnormal foam cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(261525, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0000358', 'abnormal cell morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(261526, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0002877', 'abnormal melanocyte morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(261527, 'HP:0033997', 'Perinuclear cardiomyocyte vacuolization', 'MP:0009841', 'foam cell reticulosis', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(261528, 'HP:0007042', 'Focal white matter lesions', 'MP:0008222', 'decreased hippocampal commissure size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261529, 'HP:0007042', 'Focal white matter lesions', 'MP:0020573', 'abnormal corpus callosum size', 0.41818181818181815, 10.963291078136551, 2.1411793470682574, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261530, 'HP:0007042', 'Focal white matter lesions', 'MP:0012137', 'abnormal forebrain size', 0.43478260869565216, 9.371930806217245, 2.0186016259882185, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(261531, 'HP:0007042', 'Focal white matter lesions', 'MP:0008128', 'abnormal brain internal capsule morphology', 0.40425531914893614, 10.963291078136551, 2.1052241528432964, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261532, 'HP:0007042', 'Focal white matter lesions', 'MP:0012462', 'decreased brain internal capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261533, 'HP:0007042', 'Focal white matter lesions', 'MP:0020139', 'abnormal brain external capsule morphology', 0.41304347826086957, 10.963291078136551, 2.127983994324177, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261534, 'HP:0007042', 'Focal white matter lesions', 'MP:0012461', 'increased brain internal capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261535, 'HP:0007042', 'Focal white matter lesions', 'MP:0008224', 'increased hippocampal commissure size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261536, 'HP:0007042', 'Focal white matter lesions', 'MP:0020141', 'decreased brain external capsule size', 0.45098039215686275, 10.963291078136551, 2.2235623017464246, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261537, 'HP:0007042', 'Focal white matter lesions', 'MP:0000791', 'delaminated cerebral cortex', 0.4375, 8.700256672302757, 1.9509900804802818, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(261538, 'HP:0007042', 'Focal white matter lesions', 'MP:0020569', 'abnormal premotor cortex size', 0.42, 8.700256672302757, 1.9115720761632709, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(261539, 'HP:0007042', 'Focal white matter lesions', 'MP:0020066', 'abnormal neocortex size', 0.42, 8.700256672302757, 1.9115720761632709, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(261540, 'HP:0007042', 'Focal white matter lesions', 'MP:0020140', 'increased brain external capsule size', 0.45098039215686275, 10.963291078136551, 2.2235623017464246, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(261541, 'HP:0025059', 'Splenic abscess', 'MP:0000689', 'abnormal spleen morphology', 0.40425531914893614, 11.249595263293193, 2.1325357496321016, 'UPHENO:0076790', 'abnormal spleen morphology'),
(261542, 'HP:0010909', 'Abnormal circulating arginine concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(261543, 'HP:0010909', 'Abnormal circulating arginine concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(261544, 'HP:0033712', 'Repeated implantation failure', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261545, 'HP:0033712', 'Repeated implantation failure', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261546, 'HP:0033712', 'Repeated implantation failure', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261547, 'HP:0033712', 'Repeated implantation failure', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261548, 'HP:0033712', 'Repeated implantation failure', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261549, 'HP:0033712', 'Repeated implantation failure', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261550, 'HP:0033712', 'Repeated implantation failure', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261551, 'HP:0033712', 'Repeated implantation failure', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261552, 'HP:0033712', 'Repeated implantation failure', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261553, 'HP:0033712', 'Repeated implantation failure', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261554, 'HP:0033712', 'Repeated implantation failure', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261555, 'HP:0033712', 'Repeated implantation failure', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261556, 'HP:0033712', 'Repeated implantation failure', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261557, 'HP:0033712', 'Repeated implantation failure', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261558, 'HP:0033712', 'Repeated implantation failure', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261559, 'HP:0033712', 'Repeated implantation failure', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261560, 'HP:0033712', 'Repeated implantation failure', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261561, 'HP:0033712', 'Repeated implantation failure', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261562, 'HP:0033712', 'Repeated implantation failure', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261563, 'HP:0033712', 'Repeated implantation failure', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261564, 'HP:0033712', 'Repeated implantation failure', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261565, 'HP:0033712', 'Repeated implantation failure', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261566, 'HP:0033712', 'Repeated implantation failure', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261567, 'HP:0033712', 'Repeated implantation failure', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261568, 'HP:0033712', 'Repeated implantation failure', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261569, 'HP:0033712', 'Repeated implantation failure', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261570, 'HP:0033712', 'Repeated implantation failure', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261571, 'HP:0033712', 'Repeated implantation failure', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261572, 'HP:0033712', 'Repeated implantation failure', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261573, 'HP:0033712', 'Repeated implantation failure', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261574, 'HP:0033712', 'Repeated implantation failure', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261575, 'HP:0033712', 'Repeated implantation failure', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261576, 'HP:0033712', 'Repeated implantation failure', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261577, 'HP:0033712', 'Repeated implantation failure', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261578, 'HP:0033712', 'Repeated implantation failure', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261579, 'HP:0033712', 'Repeated implantation failure', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261580, 'HP:0033712', 'Repeated implantation failure', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261581, 'HP:0033712', 'Repeated implantation failure', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(261582, 'HP:0011831', 'Deviated nasal tip', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(261583, 'HP:0011831', 'Deviated nasal tip', 'MP:0030114', 'abnormal nasal columella morphology', 0.40425531914893614, 12.002285209752415, 2.2027227782871406, 'UPHENO:0088168', 'abnormal external nose morphology'),
(261584, 'HP:0011831', 'Deviated nasal tip', 'MP:0030041', 'abnormal forehead size', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(261585, 'HP:0011831', 'Deviated nasal tip', 'MP:0030116', 'bifid nasal tip', 0.41818181818181815, 13.799792345853671, 2.402253578147117, 'UPHENO:0087430', 'abnormal nose tip morphology'),
(261586, 'HP:0011831', 'Deviated nasal tip', 'MP:0030115', 'abnormal nasal tip morphology', 0.43478260869565216, 13.799792345853671, 2.4494713134855353, 'UPHENO:0087430', 'abnormal nose tip morphology'),
(261587, 'HP:0011831', 'Deviated nasal tip', 'MP:0030063', 'abnormal face size', 0.4318181818181818, 5.913369942082322, 1.5979676645064742, 'UPHENO:0087472', 'abnormal face morphology'),
(261588, 'HP:0011831', 'Deviated nasal tip', 'MP:0030117', 'bifid nose', 0.4074074074074074, 11.126020578174659, 2.129042789263664, 'UPHENO:0021517', 'abnormal nose morphology'),
(261589, 'HP:0011831', 'Deviated nasal tip', 'MP:0030071', 'abnormal face shape', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(261590, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261591, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261592, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261593, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261594, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261595, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261596, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261597, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261598, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261599, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261600, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261601, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261602, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261603, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261604, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261605, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261606, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261607, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261608, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261609, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261610, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261611, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261612, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261613, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261614, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261615, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261616, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261617, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261618, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261619, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261620, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261621, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261622, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261623, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261624, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261625, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261626, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261627, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261628, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261629, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261630, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261631, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261632, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261633, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261634, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261635, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261636, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261637, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261638, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261639, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261640, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261641, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261642, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261643, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261644, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261645, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261646, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261647, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261648, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261649, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261650, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261651, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261652, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261653, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261654, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261655, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261656, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261657, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261658, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261659, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261660, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261661, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261662, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261663, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261664, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261665, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261666, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261667, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261668, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261669, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261670, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261671, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261672, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261673, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261674, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261675, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261676, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261677, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261678, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261679, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261680, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261681, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261682, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261683, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261684, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261685, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261686, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261687, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261688, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261689, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261690, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261691, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261692, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261693, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261694, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261695, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261696, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261697, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261698, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261699, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261700, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261701, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261702, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261703, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261704, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261705, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261706, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261707, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261708, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261709, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261710, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261711, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261712, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261713, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261714, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261715, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261716, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261717, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261718, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261719, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261720, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261721, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261722, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261723, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261724, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261725, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261726, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261727, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261728, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261729, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261730, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261731, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261732, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261733, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261734, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261735, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261736, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261737, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261738, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261739, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261740, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261741, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261742, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261743, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261744, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261745, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261746, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261747, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261748, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261749, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261750, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261751, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261752, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261753, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261754, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261755, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261756, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261757, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261758, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261759, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261760, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261761, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261762, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261763, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261764, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261765, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261766, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261767, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261768, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261769, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261770, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261771, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261772, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261773, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261774, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261775, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261776, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261777, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261778, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261779, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261780, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261781, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261782, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261783, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261784, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261785, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261786, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261787, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261788, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261789, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261790, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261791, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261792, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261793, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261794, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261795, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261796, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261797, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261798, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261799, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261800, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261801, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261802, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261803, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261804, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261805, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261806, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261807, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261808, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261809, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261810, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261811, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261812, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261813, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261814, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261815, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261816, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261817, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261818, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261819, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261820, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261821, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261822, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261823, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261824, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261825, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261826, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261827, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261828, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261829, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261830, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261831, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261832, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261833, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261834, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261835, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261836, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261837, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261838, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261839, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261840, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261841, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261842, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261843, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261844, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261845, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261846, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261847, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261848, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261849, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261850, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261851, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261852, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261853, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261854, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261855, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261856, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261857, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261858, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261859, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261860, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261861, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261862, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261863, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261864, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261865, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261866, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261867, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261868, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261869, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261870, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261871, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261872, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261873, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261874, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261875, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261876, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261877, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261878, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261879, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261880, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261881, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261882, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261883, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261884, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261885, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261886, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261887, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261888, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261889, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261890, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261891, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261892, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261893, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261894, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261895, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261896, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261897, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261898, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261899, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261900, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261901, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261902, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261903, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261904, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261905, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261906, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261907, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261908, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261909, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261910, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261911, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261912, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261913, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261914, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261915, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261916, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261917, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261918, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261919, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261920, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261921, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261922, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261923, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261924, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261925, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261926, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261927, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261928, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261929, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261930, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261931, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261932, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261933, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261934, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261935, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261936, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261937, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261938, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261939, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261940, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261941, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261942, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261943, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261944, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261945, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261946, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261947, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261948, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261949, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261950, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261951, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261952, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261953, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261954, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261955, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261956, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261957, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261958, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261959, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261960, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261961, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261962, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261963, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261964, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261965, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261966, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261967, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261968, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261969, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261970, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(261971, 'HP:0034168', 'Reduced circulating interleukin 22 concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(261972, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(261973, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261974, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001473', 'reduced long-term potentiation', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261975, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(261976, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003088', 'abnormal prepulse inhibition', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261977, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(261978, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003488', 'decreased channel response intensity', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261979, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261980, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261981, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261982, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004494', 'abnormal synaptic glutamate release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261983, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0009141', 'increased prepulse inhibition', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261984, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261985, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004835', 'abnormal miniature endplate potential', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261986, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003008', 'enhanced long-term potentiation', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261987, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261988, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0008921', 'increased neurotransmitter release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261989, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(261990, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(261991, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261992, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003490', 'decreased channel response threshold', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261993, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(261994, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002917', 'decreased synaptic depression', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261995, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003485', 'abnormal channel response threshold', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261996, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(261997, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(261998, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(261999, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001475', 'reduced long-term depression', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262000, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262001, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262002, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003990', 'decreased neurotransmitter release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262003, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262004, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262005, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002916', 'increased synaptic depression', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262006, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(262007, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(262008, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262009, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262010, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262011, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0021010', 'impaired synaptic physiology', 0.4473684210526316, 11.562753148552822, 2.2743813706345337, 'UPHENO:0084222', 'abnormality of synapse function'),
(262012, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(262013, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262014, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001898', 'abnormal long-term depression', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262015, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262016, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002915', 'abnormal synaptic depression', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262017, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262018, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0014255', 'increased paired-pulse inhibition', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262019, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002923', 'increased post-tetanic potentiation', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262020, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0014256', 'decreased paired-pulse inhibition', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262021, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262022, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003635', 'abnormal synaptic transmission', 0.4473684210526316, 11.562753148552822, 2.2743813706345337, 'UPHENO:0084222', 'abnormality of synapse function'),
(262023, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262024, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0014253', 'decreased paired-pulse ratio', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262025, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002920', 'decreased paired-pulse facilitation', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262026, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002914', 'abnormal endplate potential', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262027, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0021009', 'abnormal synaptic physiology', 0.4594594594594595, 11.562753148552822, 2.304911345691466, 'UPHENO:0084222', 'abnormality of synapse function'),
(262028, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262029, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262030, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262031, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003486', 'abnormal channel response intensity', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262032, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0010149', 'abnormal synaptic dopamine release', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262033, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262034, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002207', 'abnormal long-term potentiation', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262035, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003484', 'abnormal channel response', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(262036, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262037, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003487', 'increased channel response intensity', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262038, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262039, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262040, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004859', 'abnormal synaptic plasticity', 0.4473684210526316, 11.562753148552822, 2.2743813706345337, 'UPHENO:0084222', 'abnormality of synapse function'),
(262041, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0014254', 'increased paired-pulse ratio', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262042, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262043, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262044, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004495', 'decreased synaptic glutamate release', 0.40476190476190477, 11.562753148552822, 2.1633682046059457, 'UPHENO:0084222', 'abnormality of synapse function'),
(262045, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262046, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0001900', 'impaired synaptic plasticity', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262047, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.425, 11.562753148552822, 2.2167927481239533, 'UPHENO:0084222', 'abnormality of synapse function'),
(262048, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0003489', 'increased channel response threshold', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262049, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4358974358974359, 11.562753148552822, 2.2450332846907144, 'UPHENO:0084222', 'abnormality of synapse function'),
(262050, 'HP:0003436', 'Prolonged miniature endplate currents', 'MP:0009142', 'decreased prepulse inhibition', 0.4146341463414634, 11.562753148552822, 2.1895918069602076, 'UPHENO:0084222', 'abnormality of synapse function'),
(262051, 'HP:0011829', 'Narrow philtrum', 'MP:0003773', 'eclabion', 0.4032258064516129, 11.249595263293193, 2.129818565581501, 'UPHENO:0020955', 'abnormal lip morphology'),
(262052, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0002875', 'decreased erythrocyte cell number', 0.40298507462686567, 11.533898285880637, 2.155919493272948, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(262053, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0003179', 'thrombocytopenia', 0.5254237288135594, 14.285219173023913, 2.739670258408697, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(262054, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0013661', 'abnormal myeloid cell number', 0.40384615384615385, 10.175301480945878, 2.0271300814957747, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(262055, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0013662', 'decreased myeloid cell number', 0.46296296296296297, 11.533898285880637, 2.310793743488315, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(262056, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0011182', 'decreased hematopoietic cell number', 0.43137254901960786, 9.892901750245153, 2.0657991783336036, 'UPHENO:0085371', 'abnormally decreased number of hematopoietic cell'),
(262057, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0005505', 'thrombocytosis', 0.40625, 13.548253578857707, 2.34605584256022, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(262058, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0011898', 'abnormal platelet cell number', 0.4642857142857143, 13.548253578857707, 2.508039192314174, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(262059, 'HP:0011874', 'Heparin-induced thrombocytopenia', 'MP:0003714', 'absent platelets', 0.4492753623188406, 14.285219173023913, 2.533376604408505, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(262060, 'HP:0010777', 'Bronchomegaly', 'MP:0012672', 'enlarged trachea', 0.425531914893617, 10.774257253746534, 2.141212348353896, 'UPHENO:0076785', 'abnormal tracheobronchial tree morphology'),
(262061, 'HP:0010777', 'Bronchomegaly', 'MP:0001942', 'abnormal lung volume', 0.40425531914893614, 8.526773851447254, 1.8566081128303875, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(262062, 'HP:0010777', 'Bronchomegaly', 'MP:0010856', 'dilated respiratory conducting tube', 0.4222222222222222, 10.708293991368175, 2.126330097902097, 'UPHENO:0087478', 'abnormal respiratory tube morphology'),
(262063, 'HP:0031730', 'Axial myopia', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262064, 'HP:0031730', 'Axial myopia', 'MP:0013479', 'scleritis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262065, 'HP:0031730', 'Axial myopia', 'MP:0001389', 'abnormal eye movement', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262066, 'HP:0031730', 'Axial myopia', 'MP:0030144', 'abnormal facial muscle physiology', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(262067, 'HP:0031730', 'Axial myopia', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262068, 'HP:0031730', 'Axial myopia', 'MP:0005257', 'abnormal intraocular pressure', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262069, 'HP:0031730', 'Axial myopia', 'MP:0031497', 'increased visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262070, 'HP:0031730', 'Axial myopia', 'MP:0006251', 'eyelid apraxia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262071, 'HP:0031730', 'Axial myopia', 'MP:0020976', 'increased FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262072, 'HP:0031730', 'Axial myopia', 'MP:0011275', 'abnormal behavioral response to light', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262073, 'HP:0031730', 'Axial myopia', 'MP:0006190', 'retina ischemia', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262074, 'HP:0031730', 'Axial myopia', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262075, 'HP:0031730', 'Axial myopia', 'MP:0012150', 'increased b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262076, 'HP:0031730', 'Axial myopia', 'MP:0005258', 'ocular hypertension', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262077, 'HP:0031730', 'Axial myopia', 'MP:0003665', 'endophthalmitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262078, 'HP:0031730', 'Axial myopia', 'MP:0003878', 'abnormal ear physiology', 0.4117647058823529, 5.059610039003922, 1.4433879726497136, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262079, 'HP:0031730', 'Axial myopia', 'MP:0012145', 'increased a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262080, 'HP:0031730', 'Axial myopia', 'MP:0006153', 'hypermetropia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262081, 'HP:0031730', 'Axial myopia', 'MP:0020220', 'decreased tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262082, 'HP:0031730', 'Axial myopia', 'MP:0030006', 'decreased retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262083, 'HP:0031730', 'Axial myopia', 'MP:0005515', 'uveitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262084, 'HP:0031730', 'Axial myopia', 'MP:0012040', 'abnormal c-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262085, 'HP:0031730', 'Axial myopia', 'MP:0012039', 'abnormal b-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262086, 'HP:0031730', 'Axial myopia', 'MP:0005253', 'abnormal eye physiology', 0.53125, 8.795504987450572, 2.161622544428864, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262087, 'HP:0031730', 'Axial myopia', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262088, 'HP:0031730', 'Axial myopia', 'MP:0002090', 'abnormal vision', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262089, 'HP:0031730', 'Axial myopia', 'MP:0012031', 'abnormal b-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262090, 'HP:0031730', 'Axial myopia', 'MP:0006229', 'iris inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262091, 'HP:0031730', 'Axial myopia', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262092, 'HP:0031730', 'Axial myopia', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262093, 'HP:0031730', 'Axial myopia', 'MP:0030933', 'hyphema', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262094, 'HP:0031730', 'Axial myopia', 'MP:0012037', 'abnormal b-wave latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262095, 'HP:0031730', 'Axial myopia', 'MP:0003100', 'myopia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262096, 'HP:0031730', 'Axial myopia', 'MP:0012149', 'decreased b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262097, 'HP:0031730', 'Axial myopia', 'MP:0006072', 'abnormal retina apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262098, 'HP:0031730', 'Axial myopia', 'MP:0006252', 'lateral rectus palsy', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262099, 'HP:0031730', 'Axial myopia', 'MP:0006149', 'decreased visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262100, 'HP:0031730', 'Axial myopia', 'MP:0020960', 'increased c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262101, 'HP:0031730', 'Axial myopia', 'MP:0013478', 'corneal limbitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262102, 'HP:0031730', 'Axial myopia', 'MP:0012151', 'increased a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262103, 'HP:0031730', 'Axial myopia', 'MP:0020439', 'absent b-wave', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262104, 'HP:0031730', 'Axial myopia', 'MP:0012032', 'abnormal ERG latency', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262105, 'HP:0031730', 'Axial myopia', 'MP:0006156', 'abnormal visual pursuit', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262106, 'HP:0031730', 'Axial myopia', 'MP:0012144', 'decreased b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262107, 'HP:0031730', 'Axial myopia', 'MP:0012147', 'increased a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262108, 'HP:0031730', 'Axial myopia', 'MP:0003096', 'increased corneal light-scattering', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262109, 'HP:0031730', 'Axial myopia', 'MP:0014157', 'alacrima', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262110, 'HP:0031730', 'Axial myopia', 'MP:0012154', 'decreased b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262111, 'HP:0031730', 'Axial myopia', 'MP:0001313', 'increased incidence of corneal inflammation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262112, 'HP:0031730', 'Axial myopia', 'MP:0020961', 'abnormal c-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262113, 'HP:0031730', 'Axial myopia', 'MP:0006194', 'keratoconjunctivitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262114, 'HP:0031730', 'Axial myopia', 'MP:0020980', 'increased FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262115, 'HP:0031730', 'Axial myopia', 'MP:0001999', 'photosensitivity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262116, 'HP:0031730', 'Axial myopia', 'MP:0012146', 'increased b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262117, 'HP:0031730', 'Axial myopia', 'MP:0020958', 'abnormal c-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262118, 'HP:0031730', 'Axial myopia', 'MP:0006147', 'monocular blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262119, 'HP:0031730', 'Axial myopia', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262120, 'HP:0031730', 'Axial myopia', 'MP:0013466', 'keratoconjunctivitis sicca', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262121, 'HP:0031730', 'Axial myopia', 'MP:0030005', 'increased retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262122, 'HP:0031730', 'Axial myopia', 'MP:0020218', 'abnormal tear production', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262123, 'HP:0031730', 'Axial myopia', 'MP:0008796', 'increased lens fiber apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262124, 'HP:0031730', 'Axial myopia', 'MP:0008144', 'nyctalopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262125, 'HP:0031730', 'Axial myopia', 'MP:0011832', 'abnormal visual acuity', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262126, 'HP:0031730', 'Axial myopia', 'MP:0020861', 'abnormal corneal wound healing', 0.47368421052631576, 8.795504987450572, 2.041149635906392, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262127, 'HP:0031730', 'Axial myopia', 'MP:0008145', 'hemeralopia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262128, 'HP:0031730', 'Axial myopia', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262129, 'HP:0031730', 'Axial myopia', 'MP:0003101', 'high myopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262130, 'HP:0031730', 'Axial myopia', 'MP:0006157', 'palsy of the eye', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262131, 'HP:0031730', 'Axial myopia', 'MP:0004021', 'abnormal rod electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262132, 'HP:0031730', 'Axial myopia', 'MP:0001852', 'conjunctivitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262133, 'HP:0031730', 'Axial myopia', 'MP:0012143', 'decreased a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262134, 'HP:0031730', 'Axial myopia', 'MP:0020860', 'abnormal cornea physiology', 0.5294117647058824, 8.795504987450572, 2.1578794722795798, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262135, 'HP:0031730', 'Axial myopia', 'MP:0001848', 'choroid inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262136, 'HP:0031730', 'Axial myopia', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262137, 'HP:0031730', 'Axial myopia', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262138, 'HP:0031730', 'Axial myopia', 'MP:0012152', 'decreased a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262139, 'HP:0031730', 'Axial myopia', 'MP:0012148', 'decreased a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262140, 'HP:0031730', 'Axial myopia', 'MP:0020979', 'decreased FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262141, 'HP:0031730', 'Axial myopia', 'MP:0020977', 'decreased FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262142, 'HP:0031730', 'Axial myopia', 'MP:0012038', 'abnormal a-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262143, 'HP:0031730', 'Axial myopia', 'MP:0006145', 'legal blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262144, 'HP:0031730', 'Axial myopia', 'MP:0020962', 'increased c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262145, 'HP:0031730', 'Axial myopia', 'MP:0001851', 'eye inflammation', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262146, 'HP:0031730', 'Axial myopia', 'MP:0006224', 'oculomotor apraxia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262147, 'HP:0031730', 'Axial myopia', 'MP:0013480', 'cyclitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262148, 'HP:0031730', 'Axial myopia', 'MP:0004022', 'abnormal cone electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262149, 'HP:0031730', 'Axial myopia', 'MP:0002001', 'blindness', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262150, 'HP:0031730', 'Axial myopia', 'MP:0012153', 'increased b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262151, 'HP:0031730', 'Axial myopia', 'MP:0001337', 'dry eyes', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262152, 'HP:0031730', 'Axial myopia', 'MP:0012035', 'abnormal b-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262153, 'HP:0031730', 'Axial myopia', 'MP:0006201', 'vitreous body inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262154, 'HP:0031730', 'Axial myopia', 'MP:0008794', 'increased lens epithelium apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262155, 'HP:0031730', 'Axial myopia', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262156, 'HP:0031730', 'Axial myopia', 'MP:0013468', 'chromodacryorrhea', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262157, 'HP:0031730', 'Axial myopia', 'MP:0012033', 'abnormal ERG implicit time', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262158, 'HP:0031730', 'Axial myopia', 'MP:0002638', 'abnormal pupillary reflex', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262159, 'HP:0031730', 'Axial myopia', 'MP:0020963', 'decreased c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262160, 'HP:0031730', 'Axial myopia', 'MP:0006152', 'tunnel vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262161, 'HP:0031730', 'Axial myopia', 'MP:0020959', 'decreased c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262162, 'HP:0031730', 'Axial myopia', 'MP:0005551', 'abnormal eye electrophysiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262163, 'HP:0031730', 'Axial myopia', 'MP:0005260', 'ocular hypotension', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262164, 'HP:0031730', 'Axial myopia', 'MP:0020974', 'abnormal FO-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262165, 'HP:0031730', 'Axial myopia', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262166, 'HP:0031730', 'Axial myopia', 'MP:0006150', 'double vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262167, 'HP:0031730', 'Axial myopia', 'MP:0013787', 'photophobia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262168, 'HP:0031730', 'Axial myopia', 'MP:0006148', 'binocular blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262169, 'HP:0031730', 'Axial myopia', 'MP:0012030', 'abnormal a-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262170, 'HP:0031730', 'Axial myopia', 'MP:0012036', 'abnormal a-wave latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262171, 'HP:0031730', 'Axial myopia', 'MP:0001348', 'abnormal lacrimal gland physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262172, 'HP:0031730', 'Axial myopia', 'MP:0010748', 'abnormal visual evoked potential', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262173, 'HP:0031730', 'Axial myopia', 'MP:0010749', 'absent visual evoked potential', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262174, 'HP:0031730', 'Axial myopia', 'MP:0014132', 'abnormal tear film physiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262175, 'HP:0031730', 'Axial myopia', 'MP:0013145', 'eye discharge', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262176, 'HP:0031730', 'Axial myopia', 'MP:0020219', 'increased tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262177, 'HP:0031730', 'Axial myopia', 'MP:0005251', 'blepharitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262178, 'HP:0031730', 'Axial myopia', 'MP:0006203', 'eye hemorrhage', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262179, 'HP:0031730', 'Axial myopia', 'MP:0003011', 'delayed dark adaptation', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262180, 'HP:0031730', 'Axial myopia', 'MP:0012034', 'abnormal a-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(262181, 'HP:0007238', 'Nonarteriosclerotic cerebral calcification', 'MP:0000791', 'delaminated cerebral cortex', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(262182, 'HP:0100594', 'Esophageal web', 'MP:0000478', 'delayed intestine development', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262183, 'HP:0100594', 'Esophageal web', 'MP:0000512', 'intestinal ulcer', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262184, 'HP:0100594', 'Esophageal web', 'MP:0005213', 'gastric metaplasia', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262185, 'HP:0100594', 'Esophageal web', 'MP:0013948', 'intraembryonal intestine elongation', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262186, 'HP:0100594', 'Esophageal web', 'MP:0011974', 'intestinal stenosis', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262187, 'HP:0100594', 'Esophageal web', 'MP:0003294', 'intussusception', 0.45161290322580644, 8.258419113680198, 1.9312194675863759, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262188, 'HP:0100594', 'Esophageal web', 'MP:0003119', 'abnormal digestive system development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(262189, 'HP:0100594', 'Esophageal web', 'MP:0005494', 'esophagogastric junction metaplasia', 0.4166666666666667, 11.577399924517223, 2.196341648108397, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262190, 'HP:0100594', 'Esophageal web', 'MP:0000495', 'abnormal colon morphology', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262191, 'HP:0100594', 'Esophageal web', 'MP:0010352', 'gastrointestinal tract polyps', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(262192, 'HP:0100594', 'Esophageal web', 'MP:0000496', 'abnormal small intestine morphology', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262193, 'HP:0100594', 'Esophageal web', 'MP:0000511', 'abnormal intestinal mucosa morphology', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262194, 'HP:0100594', 'Esophageal web', 'MP:0010884', 'esophagus stenosis', 0.40625, 11.577399924517223, 2.1687136093396755, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262195, 'HP:0100594', 'Esophageal web', 'MP:0000467', 'abnormal esophagus morphology', 0.4482758620689655, 11.577399924517223, 2.2781283834938133, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262196, 'HP:0100594', 'Esophageal web', 'MP:0003160', 'abnormal esophagus development', 0.41935483870967744, 11.577399924517223, 2.2034152305054424, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262197, 'HP:0100594', 'Esophageal web', 'MP:0010158', 'abnormal intestine development', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262198, 'HP:0100594', 'Esophageal web', 'MP:0000489', 'abnormal large intestine morphology', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262199, 'HP:0100594', 'Esophageal web', 'MP:0003300', 'gastrointestinal ulcer', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(262200, 'HP:0100594', 'Esophageal web', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(262201, 'HP:0100594', 'Esophageal web', 'MP:0000470', 'abnormal stomach morphology', 0.42424242424242425, 8.258419113680198, 1.8717830390292727, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262202, 'HP:0100594', 'Esophageal web', 'MP:0003262', 'intestinal/bowel diverticulum', 0.45161290322580644, 8.258419113680198, 1.9312194675863759, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262203, 'HP:0100594', 'Esophageal web', 'MP:0008011', 'intestine polyps', 0.4375, 8.258419113680198, 1.9008046617775027, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262204, 'HP:0100594', 'Esophageal web', 'MP:0000468', 'abnormal esophageal epithelium morphology', 0.41935483870967744, 11.577399924517223, 2.2034152305054424, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262205, 'HP:0100594', 'Esophageal web', 'MP:0000488', 'abnormal intestinal epithelium morphology', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262206, 'HP:0100594', 'Esophageal web', 'MP:0009053', 'abnormal anal canal morphology', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262207, 'HP:0100594', 'Esophageal web', 'MP:0014231', 'intestinal mucus accumulation', 0.45161290322580644, 8.258419113680198, 1.9312194675863759, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262208, 'HP:0100594', 'Esophageal web', 'MP:0000477', 'abnormal intestine morphology', 0.4666666666666667, 8.258419113680198, 1.9631426131887173, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(262209, 'HP:0100594', 'Esophageal web', 'MP:0004547', 'esophageal ulcer', 0.43333333333333335, 11.577399924517223, 2.239837784444251, 'UPHENO:0076752', 'abnormal esophagus morphology'),
(262210, 'HP:0410172', 'Blood xenobiotic', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262211, 'HP:0410172', 'Blood xenobiotic', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262212, 'HP:0410172', 'Blood xenobiotic', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262213, 'HP:0410172', 'Blood xenobiotic', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262214, 'HP:0410172', 'Blood xenobiotic', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262215, 'HP:0410172', 'Blood xenobiotic', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262216, 'HP:0410172', 'Blood xenobiotic', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262217, 'HP:0410172', 'Blood xenobiotic', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262218, 'HP:0410172', 'Blood xenobiotic', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262219, 'HP:0410172', 'Blood xenobiotic', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262220, 'HP:0410172', 'Blood xenobiotic', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262221, 'HP:0410172', 'Blood xenobiotic', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262222, 'HP:0410172', 'Blood xenobiotic', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262223, 'HP:0410172', 'Blood xenobiotic', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262224, 'HP:0410172', 'Blood xenobiotic', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262225, 'HP:0410172', 'Blood xenobiotic', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(262226, 'HP:0410172', 'Blood xenobiotic', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262227, 'HP:0410172', 'Blood xenobiotic', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262228, 'HP:0031520', 'Groin pain', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262229, 'HP:0031520', 'Groin pain', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262230, 'HP:0031520', 'Groin pain', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262231, 'HP:0031520', 'Groin pain', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262232, 'HP:0031520', 'Groin pain', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262233, 'HP:0031520', 'Groin pain', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262234, 'HP:0031520', 'Groin pain', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262235, 'HP:0031520', 'Groin pain', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262236, 'HP:0031520', 'Groin pain', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262237, 'HP:0031520', 'Groin pain', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262238, 'HP:0031520', 'Groin pain', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262239, 'HP:0031520', 'Groin pain', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262240, 'HP:0031520', 'Groin pain', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262241, 'HP:0031520', 'Groin pain', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262242, 'HP:0031520', 'Groin pain', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(262243, 'HP:0031520', 'Groin pain', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262244, 'HP:0031520', 'Groin pain', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262245, 'HP:0031520', 'Groin pain', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(262246, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0004635', 'short metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(262247, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0008152', 'decreased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(262248, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0004642', 'fused metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(262249, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0030825', 'decreased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(262250, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0004641', 'elongated metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(262251, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0008158', 'increased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(262252, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0030823', 'increased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(262253, 'HP:0008133', 'Distal tapering of metatarsals', 'MP:0030827', 'femur fracture', 0.43283582089552236, 7.694257931681313, 1.8249247787350484, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(262254, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011289', 'abnormal nephron number', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262255, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262256, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011344', 'abnormal loop of Henle ascending limb thick segment morphology', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262257, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011383', 'abnormal kidney capsule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262258, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262259, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004969', 'pale kidney', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262260, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262261, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011402', 'renal cast', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262262, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262263, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.47368421052631576, 10.047451525800549, 2.1815863823833013, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262264, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004757', 'abnormal distal convoluted tubule morphology', 0.45, 10.047451525800549, 2.1263473814525806, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262265, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262266, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4473684210526316, 8.69825431939161, 1.9726439873379225, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262267, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0009860', 'nephrosclerosis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262268, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0003014', 'abnormal kidney medulla morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262269, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0000521', 'abnormal kidney cortex morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262270, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011381', 'abnormal kidney lobe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262271, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011351', 'absent proximal convoluted tubule brush border', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262272, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262273, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0000527', 'abnormal kidney development', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262274, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.47058823529411764, 8.472720947690348, 1.9967881206860945, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(262275, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0002135', 'abnormal kidney morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262276, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011352', 'proximal convoluted tubule brush border loss', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262277, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262278, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262279, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011567', 'increased renal glomerulus lobularity', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262280, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0020518', 'renal glomerular protein deposits', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262281, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0000523', 'cortical renal glomerulopathies', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262282, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262283, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011342', 'abnormal loop of Henle ascending limb morphology', 0.45, 10.047451525800549, 2.1263473814525806, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262284, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0002703', 'abnormal renal tubule morphology', 0.5, 10.047451525800549, 2.2413669407083425, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262285, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011331', 'abnormal papillary duct morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262286, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011506', 'glomerular crescent', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262287, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0003881', 'abnormal nephron morphology', 0.4857142857142857, 8.69825431939161, 2.055447976404291, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262288, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011534', 'granular kidney', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262289, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262290, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4473684210526316, 8.69825431939161, 1.9726439873379225, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262291, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262292, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011483', 'renal glomerular synechia', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262293, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011561', 'renal glomerulus lipidosis', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262294, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011350', 'abnormal proximal convoluted tubule brush border morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262295, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262296, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011341', 'abnormal loop of Henle descending limb morphology', 0.45, 10.047451525800549, 2.1263473814525806, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262297, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262298, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011382', 'abnormal kidney lobule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262299, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262300, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004755', 'abnormal loop of Henle morphology', 0.47368421052631576, 10.047451525800549, 2.1815863823833013, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262301, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4473684210526316, 8.69825431939161, 1.9726439873379225, 'UPHENO:0076756', 'abnormal nephron morphology'),
(262302, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0004756', 'abnormal proximal convoluted tubule morphology', 0.45, 10.047451525800549, 2.1263473814525806, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(262303, 'HP:0032590', 'Renal neutrophilic tubulitis', 'MP:0011364', 'abnormal metanephros morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(262304, 'HP:0000283', 'Broad face', 'MP:0020302', 'large horns', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262305, 'HP:0000283', 'Broad face', 'MP:0030041', 'abnormal forehead size', 0.425531914893617, 5.913369942082322, 1.5862936786511657, 'UPHENO:0087472', 'abnormal face morphology'),
(262306, 'HP:0000283', 'Broad face', 'MP:0030071', 'abnormal face shape', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0020809', 'abnormal face morphology'),
(262307, 'HP:0000283', 'Broad face', 'MP:0001305', 'enlarged lens', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262308, 'HP:0000283', 'Broad face', 'MP:0013396', 'eyelid hyperplasia', 0.43137254901960786, 5.9605885577567275, 1.603506869276408, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262309, 'HP:0000283', 'Broad face', 'MP:0030067', 'narrow face', 0.43137254901960786, 13.607147267911277, 2.4227566534516174, 'UPHENO:0075171', 'abnormal size of face'),
(262310, 'HP:0000283', 'Broad face', 'MP:0000434', 'megacephaly', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262311, 'HP:0000283', 'Broad face', 'MP:0030066', 'short face', 0.4230769230769231, 13.607147267911277, 2.3993478276320137, 'UPHENO:0075171', 'abnormal size of face'),
(262312, 'HP:0000283', 'Broad face', 'MP:0006162', 'thick eyelids', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262313, 'HP:0000283', 'Broad face', 'MP:0011496', 'abnormal head size', 0.4186046511627907, 4.6730878730104815, 1.3986337329460563, 'UPHENO:0087907', 'abnormal head morphology'),
(262314, 'HP:0000283', 'Broad face', 'MP:0009274', 'buphthalmos', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262315, 'HP:0000283', 'Broad face', 'MP:0001296', 'macrophthalmia', 0.43137254901960786, 5.9605885577567275, 1.603506869276408, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262316, 'HP:0000283', 'Broad face', 'MP:0030068', 'large face', 0.5681818181818182, 15.022184767190119, 2.921529095197461, 'UPHENO:0001260', 'increased size of the face'),
(262317, 'HP:0000283', 'Broad face', 'MP:0030064', 'small face', 0.46808510638297873, 13.607147267911277, 2.5237478036581047, 'UPHENO:0075171', 'abnormal size of face'),
(262318, 'HP:0000283', 'Broad face', 'MP:0009829', 'enlarged eye anterior chamber', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262319, 'HP:0000283', 'Broad face', 'MP:0030032', 'high forehead', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262320, 'HP:0000283', 'Broad face', 'MP:0000346', 'broad head', 0.41509433962264153, 9.252530554317739, 1.959763521520603, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262321, 'HP:0000283', 'Broad face', 'MP:0002697', 'abnormal eye size', 0.40816326530612246, 5.913369942082322, 1.5535830793759942, 'UPHENO:0087472', 'abnormal face morphology'),
(262322, 'HP:0000283', 'Broad face', 'MP:0000446', 'long snout', 0.43137254901960786, 5.9605885577567275, 1.603506869276408, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262323, 'HP:0000283', 'Broad face', 'MP:0030251', 'broad frontonasal prominence', 0.4489795918367347, 9.252530554317739, 2.038184827667622, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262324, 'HP:0000283', 'Broad face', 'MP:0003759', 'broad palate', 0.42105263157894735, 9.252530554317739, 1.9737786954621077, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262325, 'HP:0000283', 'Broad face', 'MP:0030070', 'long face', 0.5102040816326531, 15.022184767190119, 2.7684616636789943, 'UPHENO:0001260', 'increased size of the face'),
(262326, 'HP:0000283', 'Broad face', 'MP:0030189', 'broad snout', 0.5, 9.252530554317739, 2.1508754676082176, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262327, 'HP:0000283', 'Broad face', 'MP:0030042', 'large forehead', 0.4489795918367347, 5.9605885577567275, 1.635904220230612, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(262328, 'HP:0000283', 'Broad face', 'MP:0030074', 'coarse facial features', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(262329, 'HP:0000283', 'Broad face', 'MP:0030065', 'face hypoplasia', 0.4230769230769231, 13.607147267911277, 2.3993478276320137, 'UPHENO:0075171', 'abnormal size of face'),
(262330, 'HP:0000283', 'Broad face', 'MP:0030069', 'broad face', 0.6222222222222222, 16.607147267911277, 3.214550680547977, 'UPHENO:0006186', 'increased width of face'),
(262331, 'HP:0000283', 'Broad face', 'MP:0030063', 'abnormal face size', 0.5116279069767442, 13.607147267911277, 2.638521608136983, 'UPHENO:0075171', 'abnormal size of face'),
(262332, 'HP:0000283', 'Broad face', 'MP:0000449', 'broad nasal bridge', 0.42105263157894735, 9.252530554317739, 1.9737786954621077, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262333, 'HP:0002905', 'Hyperphosphatemia', 'MP:0001566', 'increased circulating phosphate level', 0.4339622641509434, 15.022184767190119, 2.553245251452284, 'UPHENO:0068130', 'increased level of phosphate in blood'),
(262334, 'HP:0000092', 'Renal tubular atrophy', 'MP:0011844', 'kidney collecting duct atrophy', 0.42857142857142855, 10.052558416233639, 2.0756298613295647, 'UPHENO:0013936', 'anatomical entity atrophy'),
(262335, 'HP:0000092', 'Renal tubular atrophy', 'MP:0011346', 'renal tubule atrophy', 0.4406779661016949, 15.192109768632433, 2.5874365757704343, 'UPHENO:0013924', 'nephron tubule atrophy'),
(262336, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0009345', 'abnormal trabecular bone thickness', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262337, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010103', 'small thoracic cage', 0.45714285714285713, 6.976576768886775, 1.7858589634137918, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262338, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000013', 'abnormal adipose tissue distribution', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262339, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013941', 'abnormal enthesis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262340, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000161', 'scoliosis', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262341, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000067', 'osteopetrosis', 0.40625, 4.825104621810128, 1.4000709812757226, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262342, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0009877', 'exostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262343, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010973', 'increased periosteum thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262344, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262345, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004669', 'enlarged vertebral body', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262346, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000134', 'abnormal compact bone thickness', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262347, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002229', 'neurodegeneration', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262348, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010926', 'increased osteoid volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262349, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010124', 'decreased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262350, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010104', 'enlarged thoracic cage', 0.45714285714285713, 6.976576768886775, 1.7858589634137918, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262351, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0020009', 'abnormal bone mineral density of femur', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262352, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262353, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004674', 'thin ribs', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262354, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010971', 'abnormal periosteum morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262355, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0001259', 'abnormal body weight', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262356, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010874', 'abnormal bone volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262357, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003201', 'extremity edema', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262358, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013304', 'osteophytes', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262359, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0006322', 'abnormal perichondrium morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262360, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002932', 'abnormal joint morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262361, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004624', 'abnormal thoracic cage morphology', 0.4482758620689655, 6.976576768886775, 1.7684544001367515, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262362, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000150', 'abnormal rib morphology', 0.41935483870967744, 6.976576768886775, 1.7104564378148297, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262363, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010123', 'increased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262364, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262365, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002632', 'vestigial tail', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262366, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031312', 'spondylolysis', 0.41935483870967744, 6.976576768886775, 1.7104564378148297, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262367, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0005504', 'abnormal ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262368, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0005406', 'abnormal heart size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262369, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0001253', 'abnormal body height', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262370, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013844', 'abnormal perichondrial ossification', 0.4838709677419355, 4.825104621810128, 1.5279816892919078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262371, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0014167', 'ectopic bone', 0.40625, 4.825104621810128, 1.4000709812757226, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262372, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003198', 'calcified tendon', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262373, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010927', 'decreased osteoid volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262374, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262375, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010875', 'increased bone volume', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262376, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002113', 'abnormal skeleton development', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262377, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003200', 'calcified joint', 0.46875, 4.825104621810128, 1.503917481603794, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262378, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262379, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010119', 'abnormal bone mineral density', 0.43333333333333335, 4.825104621810128, 1.4459870917304398, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262380, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010113', 'abnormal sacrum morphology', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262381, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004671', 'long ribs', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262382, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000163', 'abnormal cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262383, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031349', 'monostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262384, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004672', 'short ribs', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262385, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004675', 'rib fractures', 0.45714285714285713, 6.976576768886775, 1.7858589634137918, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262386, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004703', 'abnormal vertebral column morphology', 0.43333333333333335, 6.976576768886775, 1.738730360498028, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262387, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004174', 'abnormal spine curvature', 0.41935483870967744, 6.976576768886775, 1.7104564378148297, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262388, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003950', 'abnormal plasma membrane morphology', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262389, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003189', 'fused joints', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262390, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010928', 'abnormal osteoid thickness', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262391, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262392, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031094', 'organomegaly', 0.43333333333333335, 3.067140347159989, 1.1528634569783167, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262393, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002114', 'abnormal axial skeleton morphology', 0.48148148148148145, 6.976576768886775, 1.8327827253531424, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262394, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262395, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004677', 'truncated ribs', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262396, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0001256', 'abnormal body length', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262397, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010099', 'abnormal thoracic cage shape', 0.4444444444444444, 6.976576768886775, 1.7608806848199283, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262398, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003956', 'abnormal body size', 0.4482758620689655, 3.067140347159989, 1.1725719522526752, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262399, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000566', 'synostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262400, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0011999', 'abnormal tail length', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262401, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262402, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010876', 'decreased bone volume', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262403, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262404, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000155', 'asymmetric rib joints', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262405, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0005422', 'osteosclerosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262406, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262407, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000160', 'kyphosis', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262408, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0030222', 'hyperostosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262409, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0005605', 'increased bone mass', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262410, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002936', 'joint swelling', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262411, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031313', 'spondylolisthesis', 0.41935483870967744, 6.976576768886775, 1.7104564378148297, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262412, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000166', 'abnormal chondrocyte morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262413, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262414, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000162', 'lordosis', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262415, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004986', 'abnormal osteoblast morphology', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262416, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0021136', 'abnormal vertebrae shape', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262417, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000137', 'abnormal vertebrae morphology', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262418, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013328', 'visceromegaly', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262419, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000358', 'abnormal cell morphology', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(262420, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4117647058823529, 6.976576768886775, 1.6949065110814576, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262421, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010122', 'abnormal bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262422, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0002582', 'disorganized extraembryonic tissue', 0.43333333333333335, 3.067140347159989, 1.1528634569783167, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262423, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003795', 'abnormal bone structure', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262424, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262425, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0008771', 'elongated vertebral column', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262426, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003141', 'cardiac fibrosis', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262427, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004704', 'short vertebral column', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262428, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000749', 'muscle degeneration', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262429, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0013614', 'abnormal areal bone mineral density', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262430, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0000071', 'axial skeleton hypoplasia', 0.45714285714285713, 6.976576768886775, 1.7858589634137918, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262431, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003988', 'disorganized embryonic tissue', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262432, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0003199', 'calcified muscle', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(262433, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0010974', 'decreased periosteum thickness', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262434, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004676', 'wide ribs', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262435, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0008753', 'abnormal osteocyte morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262436, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0031348', 'bone fibrous dysplasia', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(262437, 'HP:0009121', 'Abnormal axial skeleton morphology', 'MP:0004610', 'small vertebrae', 0.43243243243243246, 6.976576768886775, 1.7369220080997616, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(262438, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262439, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011892', 'abnormal circulating transferrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262440, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005667', 'abnormal circulating leptin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262441, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0004730', 'abnormal circulating gastrin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262442, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262443, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262444, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012666', 'increased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262445, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012615', 'decreased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262446, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012619', 'increased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262447, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262448, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262449, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0009699', 'hyperchylomicronemia', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262450, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012614', 'abnormal circulating factor IX level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262451, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262452, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0013255', 'abnormal circulating thrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262453, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020248', 'decreased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262454, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262455, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012327', 'abnormal circulating factor VIII level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262456, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262457, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262458, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011889', 'abnormal circulating ferritin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262459, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012332', 'decreased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262460, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262461, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031083', 'increased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262462, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262463, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012222', 'decreased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262464, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262465, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262466, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020256', 'abnormal circulating factor XII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262467, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0001560', 'abnormal circulating insulin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262468, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031076', 'decreased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262469, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262470, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262471, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020983', 'abnormal circulating factor XI level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262472, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031065', 'increased circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262473, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012617', 'abnormal circulating factor X level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262474, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262475, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011887', 'decreased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262476, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020255', 'absent circulating factor XII protein', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262477, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262478, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012333', 'increased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262479, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0013257', 'decreased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262480, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031079', 'increased circulating troponin I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262481, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011885', 'abnormal circulating lipase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262482, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0003349', 'abnormal circulating renin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262483, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262484, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031082', 'decreased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262485, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0008805', 'decreased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262486, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012326', 'increased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262487, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011912', 'abnormal circulating fibronectin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262488, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262489, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011894', 'decreased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262490, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012618', 'decreased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262491, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031077', 'increased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262492, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262493, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0002965', 'increased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262494, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031078', 'increased circulating troponin T level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262495, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020246', 'abnormal circulating arginase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262496, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020985', 'increased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262497, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012616', 'increased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262498, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262499, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262500, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0013256', 'increased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262501, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031108', 'increased circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262502, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005416', 'abnormal circulating protein level', 0.4444444444444444, 8.144985856518405, 1.9026281071213522, 'UPHENO:0046362', 'abnormal protein level'),
(262503, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011890', 'increased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262504, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0002941', 'increased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262505, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262506, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262507, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012622', 'increased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262508, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262509, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005419', 'decreased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262510, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262511, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0002695', 'abnormal circulating glucagon level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262512, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011888', 'abnormal circulating total protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262513, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262514, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262515, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262516, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012324', 'abnormal circulating antithrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262517, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262518, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011891', 'decreased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262519, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4074074074074074, 8.670509328908704, 1.8794759180666387, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262520, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012325', 'decreased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262521, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020247', 'increased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262522, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(262523, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031075', 'abnormal circulating troponin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262524, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020258', 'decreased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262525, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262526, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262527, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0008804', 'abnormal circulating amylase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262528, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012328', 'decreased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262529, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0008806', 'increased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262530, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031107', 'abnormal circulating myoglobin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262531, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262532, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011893', 'increased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262533, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262534, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0001570', 'abnormal circulating enzyme level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262535, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0008820', 'abnormal blood uric acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(262536, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262537, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012221', 'abnormal circulating prothrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262538, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020984', 'decreased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262539, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(262540, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012223', 'increased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262541, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262542, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262543, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012329', 'increased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(262544, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0020257', 'increased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262545, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0012621', 'decreased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262546, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0011886', 'increased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(262547, 'HP:0030136', 'Enhanced ristocetin cofactor assay activity', 'MP:0031081', 'abnormal circulating D-dimer level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262548, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0003991', 'arteriosclerosis', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262549, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0003387', 'aorta coarctation', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262550, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000259', 'abnormal vascular development', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262551, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013872', 'abnormal jugular vein morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262552, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013811', 'abnormal orbital vein morphology', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262553, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0012253', 'abnormal intersomitic vessel morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262554, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010544', 'interrupted aorta', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262555, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000272', 'abnormal aorta morphology', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262556, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0012562', 'blood vessel degeneration', 0.4166666666666667, 6.970522647367627, 1.704225465249002, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262557, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0004112', 'abnormal arteriole morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262558, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0020330', 'increased capillary density', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262559, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0020373', 'abnormal blood vessel lumen formation', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262560, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010456', 'hemitruncus', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262561, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005412', 'vascular stenosis', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262562, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0002845', 'abnormal aortic weight', 0.41025641025641024, 9.15319077934013, 1.9378222806862748, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262563, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0011569', 'abnormal azygos vein morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262564, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0006062', 'abnormal vena cava morphology', 0.4411764705882353, 9.15319077934013, 2.0095204409634797, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262565, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0001614', 'abnormal blood vessel morphology', 0.4666666666666667, 6.970522647367627, 1.8035827036128838, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262566, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0009577', 'abnormal developmental vascular remodeling', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262567, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0006063', 'abnormal inferior vena cava morphology', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262568, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000260', 'abnormal angiogenesis', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262569, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005341', 'decreased susceptibility to atherosclerosis', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262570, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005413', 'vascular restenosis', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262571, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013987', 'absent intrahepatic inferior vena cava segment', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262572, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013925', 'abnormal vascular plexus formation', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262573, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000265', 'blood vessel atresia', 0.4166666666666667, 6.970522647367627, 1.704225465249002, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262574, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0014264', 'abnormal perivascular vein cell coverage', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262575, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0002725', 'abnormal vein morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262576, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0004125', 'abnormal venule morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262577, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0002846', 'abnormal aortic mass', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262578, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0009489', 'abnormal blood vessel endothelium morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262579, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013976', 'abnormal left vena cava superior connection', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262580, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000255', 'blood vessel congestion', 0.45161290322580644, 6.970522647367627, 1.7742542010036015, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262581, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0003658', 'abnormal capillary morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262582, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0011991', 'aortic cartilaginous metaplasia', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262583, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0003227', 'abnormal vascular branching morphogenesis', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262584, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013869', 'vascular diverticulum', 0.45161290322580644, 6.970522647367627, 1.7742542010036015, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262585, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000484', 'abnormal pulmonary artery morphology', 0.42857142857142855, 9.15319077934013, 1.9806049702776742, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262586, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0003710', 'abnormal physiological neovascularization', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262587, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0006083', 'abnormal blood vessel elastic tissue morphology', 0.45454545454545453, 6.970522647367627, 1.7800054452633294, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262588, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0031193', 'pulmonary arterial medial hypertrophy', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262589, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0020328', 'abnormal capillary density', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262590, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005338', 'atherosclerotic lesions', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262591, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010668', 'abnormal hepatic portal vein morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262592, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0020329', 'decreased capillary density', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262593, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005340', 'abnormal susceptibility to atherosclerosis', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262594, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005601', 'increased angiogenesis', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262595, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0006136', 'varicose veins', 0.42424242424242425, 6.970522647367627, 1.719648634505306, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262596, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0011655', 'abnormal systemic artery morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262597, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0000486', 'abnormal pulmonary trunk morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262598, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0002191', 'abnormal artery morphology', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262599, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010462', 'pulmonary artery aneurysm', 0.40540540540540543, 9.15319077934013, 1.9263314924102248, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262600, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013983', 'abnormal superior mesenteric vein morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262601, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010461', 'discontinuous pulmonary artery', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262602, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0010017', 'visceral vascular congestion', 0.4375, 6.970522647367627, 1.7463114436501115, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262603, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0006064', 'abnormal superior vena cava morphology', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262604, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0001619', 'abnormal vascular permeability', 0.41025641025641024, 7.347404004220494, 1.7361795965495836, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(262605, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013812', 'enlarged orbital veins', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262606, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0005602', 'decreased angiogenesis', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262607, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0002726', 'abnormal pulmonary vein morphology', 0.42857142857142855, 9.15319077934013, 1.9806049702776742, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262608, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013980', 'abnormal pulmonary artery origin', 0.4166666666666667, 9.15319077934013, 1.9529028371610608, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(262609, 'HP:0011603', 'Congenital malformation of the great arteries', 'MP:0013863', 'abnormal paraumbilical vein morphology', 0.4117647058823529, 6.970522647367627, 1.694170949975123, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(262610, 'HP:0500142', 'Hypolysinemia', 'MP:0030719', 'decreased circulating lysine level', 0.4578313253012048, 16.607147267911277, 2.7574031702201443, 'UPHENO:0034327', 'decreased level of lysine in blood'),
(262611, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0000439', 'enlarged cranium', 0.43333333333333335, 7.821422361825214, 1.8410005495538542, 'UPHENO:0087814', 'abnormal cranium morphology'),
(262612, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030288', 'broad occipital bone', 0.4603174603174603, 9.252530554317739, 2.063759037841687, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262613, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030315', 'small neurocranium', 0.4098360655737705, 8.373527591151573, 1.8525046836461636, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262614, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0000441', 'increased cranium width', 0.45161290322580644, 9.252530554317739, 2.044153170831607, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262615, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0004375', 'enlarged frontal bone', 0.4090909090909091, 8.373527591151573, 1.8508198222847105, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262616, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0004386', 'enlarged interparietal bone', 0.43548387096774194, 8.373527591151573, 1.9095905867619578, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262617, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030278', 'thick neurocranium', 0.4090909090909091, 8.373527591151573, 1.8508198222847105, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262618, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030316', 'enlarged neurocranium', 0.4576271186440678, 8.373527591151573, 1.9575375614340829, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262619, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030287', 'enlarged occipital bone', 0.4426229508196721, 8.373527591151573, 1.9251793400006791, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262620, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0004421', 'enlarged parietal bone', 0.42857142857142855, 8.373527591151573, 1.8943744830212697, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262621, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030029', 'wide cranial sutures', 0.4057971014492754, 9.252530554317739, 1.9376919466243843, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262622, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0010031', 'abnormal cranium size', 0.41379310344827586, 7.821422361825214, 1.7990137944105373, 'UPHENO:0087814', 'abnormal cranium morphology'),
(262623, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0004379', 'wide frontal bone', 0.4264705882352941, 9.252530554317739, 1.9864370486287548, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262624, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030282', 'broad supraoccipital bone', 0.4603174603174603, 9.252530554317739, 2.063759037841687, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(262625, 'HP:0005445', 'Enlarged posterior fossa', 'MP:0030279', 'thin neurocranium', 0.4032258064516129, 8.373527591151573, 1.8375043988483195, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(262626, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0012601', 'decreased alpha-fetoprotein level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(262627, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0013215', 'abnormal haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262628, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0004893', 'decreased adiponectin level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(262629, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0020294', 'abnormal guanylate cyclase activating protein-2 level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262630, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0020252', 'abnormal collagen level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262631, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0010999', 'proteinosis', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262632, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0020297', 'abnormal UDP-N-acetylglucosamine-1-phosphotransferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262633, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0031228', 'decreased angiotensin II level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(262634, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0011288', 'decreased erythropoietin level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(262635, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0021030', 'decreased tumor necrosis factor (ligand) superfamily member 11 level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(262636, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0008835', 'abnormal intercellular signaling peptide or protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262637, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0021033', 'decreased tumor necrosis factor receptor superfamily member 11b level', 0.4444444444444444, 10.243742537047755, 2.1337231453283985, 'UPHENO:0081724', 'decreased level of protein'),
(262638, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0008469', 'abnormal protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(262639, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0031337', 'abnormal lipocalin 2 level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262640, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0008838', 'decreased transforming growth factor beta level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(262641, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0021149', 'abnormal amyloid beta protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262642, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0002868', 'decreased glutamic acid decarboxylase level', 0.42857142857142855, 10.243742537047755, 2.0952745340457097, 'UPHENO:0081724', 'decreased level of protein'),
(262643, 'HP:0003654', 'Reduced dihydropyrimidine dehydrogenase level', 'MP:0020291', 'abnormal dystrophin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(262644, 'HP:0006623', 'Costochondral joint sclerosis', 'MP:0010099', 'abnormal thoracic cage shape', 0.4090909090909091, 11.92532322793753, 2.2087420221745906, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(262645, 'HP:0006623', 'Costochondral joint sclerosis', 'MP:0004675', 'rib fractures', 0.4186046511627907, 11.297292005324488, 2.174649162272628, 'UPHENO:0083650', 'abnormal rib morphology'),
(262646, 'HP:0006623', 'Costochondral joint sclerosis', 'MP:0010104', 'enlarged thoracic cage', 0.4186046511627907, 11.92532322793753, 2.2342774603514033, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(262647, 'HP:0006623', 'Costochondral joint sclerosis', 'MP:0010103', 'small thoracic cage', 0.4186046511627907, 11.92532322793753, 2.2342774603514033, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(262648, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262649, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262650, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262651, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262652, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262653, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262654, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262655, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262656, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262657, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262658, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262659, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262660, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262661, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262662, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262663, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262664, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262665, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262666, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262667, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262668, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262669, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262670, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262671, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262672, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262673, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262674, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262675, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262676, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262677, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262678, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262679, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262680, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262681, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262682, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262683, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262684, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262685, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262686, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262687, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262688, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262689, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262690, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262691, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262692, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262693, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262694, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262695, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262696, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262697, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262698, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262699, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262700, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262701, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262702, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262703, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262704, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262705, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262706, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262707, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262708, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262709, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262710, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262711, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262712, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262713, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262714, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262715, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262716, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262717, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262718, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262719, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262720, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262721, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262722, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262723, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262724, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262725, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262726, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262727, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262728, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262729, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262730, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262731, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262732, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262733, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262734, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262735, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262736, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262737, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262738, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262739, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262740, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262741, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262742, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262743, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262744, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262745, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262746, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262747, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262748, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262749, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262750, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262751, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262752, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262753, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262754, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262755, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262756, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262757, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262758, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262759, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262760, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262761, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262762, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262763, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262764, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262765, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262766, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262767, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262768, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262769, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262770, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262771, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262772, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262773, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262774, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262775, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262776, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262777, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262778, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262779, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262780, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262781, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(262782, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(262783, 'HP:0032729', 'Focal emotional seizure with pleasure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
